Supplements

now browsing by category

 
Posted by: | Posted on: October 1, 2026

Why Simpler Supplement Routines Make More Sense


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/09/30/simple-supplement-routine.aspx

Analysis by Dr. Joseph Mercola     September 30, 2026

Story at-a-glance

  • Every so often, someone takes an industry that had become cold and complicated puts the humanity back into it. The way we take supplements is overdue for exactly that
  • For decades, supplements were one of the least human corners of health, requiring people to take fistfuls of pills and capsules and maintaining a dosing schedule that was easily forgotten on a busy day
  • This article series has presented one idea from several angles: removing the burden that makes people quit, retiring the pill pile, abandoning the mega-dose game, and meeting the inevitable backsliding with forgiveness instead of shame
  • Underneath all of it is a single conviction: optimal health depends first and foremost on real food, and supplements designed to add nutrition to the meals you’re already eating is one of the most effective ways to improve adherence long term
  • The simpler and more natural a health routine is, the more likely you are to keep doing it. Complexity is one of the most common routine breakers

Every once in a while, someone looks at an industry that has become too complicated and decides it doesn’t have to be that way. Nest did it with the thermostat, turning a fussy household control panel into something people could understand at a glance.

The invention of GPS-enabled digital mapping revolutionized navigation. If you’re old enough, you’ll remember the multi-step procedure we had to go through: planning routes the night before, printing the turn-by-turn sheet, unfolding a map at a red light, or pulling over to ask a stranger for directions. Now you just enter a destination, and a voice guides you the whole way, rerouting on its own when you miss a turn. Now, anyone with a smartphone can drive to unfamiliar destinations without the hassle of getting lost.

Supplements have been waiting their turn. For as long as most of us can remember, they’ve involved remembering to take fistfuls of pills and capsules, turning into a clinical chore performed out of a sense of obligation to one’s health — and abandoned due to the complexity of the schedules and the busyness of modern life.

A supplement routine that only works when days are relaxed and organized usually ends in feelings of personal failure. But the failure was in the design, not you. And a design problem is something that can be fixed, which is precisely what we’re doing.

One Idea, Told Ten Ways

Everything in this article series has been a single idea told from several angles: by redesigning supplements to fit modern lifestyles, we can help people improve their nutrition and hence their health — as opposed to insisting that people just work on their willpower.

The hidden burden that makes so many people quit a supplement routine is removed, by design, because the research shows that complicated regimens and plain forgetfulness are among the biggest reasons people stop a daily routine, while a simplified one is among the strongest factors that keep them going.1

The fistful of pills oftentimes doesn’t fit the way people live, simply because they forget to take them when busy, and most days are that way. For many, a simpler food-centered model, where nutritional powder is added to food you’re eating anyway, is the answer to that dilemma.

The mega-dose game is also up for revision, as how much of a nutrient actually reaches you depends heavily on its form and delivery method, not the total dose.2 The psychology of why we quit is also being addressed by coming up with a routine so simple it can survive your worst days, anchored to something you already do, because a behavior repeated in a stable, everyday context is the kind that becomes automatic and lasts.3

Food-centered supplementation even tackles the self-blame that comes from backsliding. When you view a nutritional supplement as part of your diet, you’re less likely to view a missed dose as a personal failure. And without the self-shaming, you’re more likely to just pick up where you left off. As research has shown, treating yourself kindly after a slip is linked to better follow-through.4

The test every decision in this approach must pass is “does this fit the life of a busy, imperfect person?” When the answer is yes, the engineering has done its job — by disappearing into a routine so natural you barely think of it as a routine at all.

The Bottom Line

The whole article series comes down to this: a supplement only helps if you take it, you’ll only keep taking it if it fits your real life, and fitting your life is a design choice the industry has spent decades ignoring. We’re choosing to make it a central point instead. We want to make supplements you’ll use long enough for them to make a difference. We’ve been working toward this for a long time, and we’re glad you’re here for it.

Frequently Asked Questions

Q: Why do so many supplement routines fail?

A: Most fail because they ask too much of you. A complicated routine depends on a calm, organized day, and real life rarely works that way. When you have to remember multiple bottles, doses, and timing rules, the routine becomes easy to skip. A better model removes as much friction as possible so consistency feels less like a daily test.

Q: Why does a food-first supplement format make sense?

A: A food-first format connects supplements to the way you already nourish yourself. Instead of treating supplements like a separate clinical task, you add nutrition to a meal you already planned to eat. That makes the routine feel more natural and much easier to repeat.

Q: Are fewer pills really better?

A: Fewer pills can make a routine easier to keep. The point is not to remove useful nutrients. The point is to stop turning supplementation into a pile of capsules that feels like a clinical chore. A simpler format with fewer pills can help you stay consistent without relying so heavily on willpower.

Q: Why is the “mega-dose” approach being reconsidered?

A: More is not always better. The amount listed on a label does not tell you how much your body can absorb or use. Nutrient form, delivery method, and dose all matter. A sensible supplement focuses on what reaches you in a useful form, not just what looks impressive on the bottle.

Q: What’s the main takeaway from this article series?

A: A supplement only helps if you actually take it, and you’ll only keep taking it if the routine fits the life you live. Make it simple, food-first, and staying consistent stops being such a battle.

These statements have not been evaluated by the U.S. Food and Drug Administration.

This article is for general education. The products described are dietary supplements intended to support normal health and wellbeing as part of a food-first lifestyle. They are not a substitute for a varied diet, a healthy lifestyle, or the advice of your physician. If you are pregnant, nursing, taking medication, or managing a health condition, talk with your healthcare provider before beginning any supplement.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your health regimen.

– Sources and References

Posted in Supplements | No Comments »

Posted by: | Posted on: September 15, 2026

The Future of Simple Nutrition


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/09/15/simple-nutrition.aspx

Analysis by Dr. Joseph Mercola     September 15, 2026

simple nutrition

Story at-a-glance

  • For decades the supplement industry has competed in one direction only — toward more ingredients, more milligrams, more capsules — on the unspoken assumption that more is better and a complex, multi-ingredient supplement is better than a simpler one with fewer ingredients
  • The complexity of many supplement routines works against the only outcome that matters — whether you take it, consistently, for long enough to make a difference
  • Higher doses do not guarantee that more reaches your cells. In a poorly absorbed form, a larger dose simply means more is wasted
  • Simplicity is the harder achievement; it’s easy to throw more into a bottle, and genuinely difficult to deliver what the body needs in a form that’s effective, effortless to take, and simple enough to fit a busy lifestyle
  • The future we’re building toward is fewer things to take, food-centered formats that fold into a meal. In short, a supplement routine you can actually adhere to, because consistency is the entire ballgame

For decades, the supplement industry has competed in one direction only: toward “more.” More ingredients, more milligrams, more capsules, more complexity, longer labels nobody reads. The unspoken assumption was that progress meant addition — that a better supplement was always a more complicated one. We think that era is ending, and that the real breakthrough runs the other way. The future of nutrition isn’t more. It’s less.

Where Complexity Actually Leads

Look at where all that addition actually leads. It leads to the fistful of pills no one wants to take. It leads to supplement routines so elaborate they collapse the first busy week. It leads to labels packed with names you can’t pronounce and forms your body can barely use. Complexity has been quietly working against the only outcome that matters — whether you take your supplements, consistently, for long enough to support your health. All that addition has mostly added friction that often results in dropped routines.

That’s the consistent finding whenever researchers look at why people stop their daily pill regimens. Even with prescription medicine — which people have strong reasons to keep up — a meta-analysis of real-world data found that roughly one in five people don’t take their daily oral medicines as directed, and about one in four abandon it within the first year.1

The reviewers’ list of fixes wasn’t “try harder”; it led with simplifying the dosing regimen. If a complicated routine sheds a quarter of its users in 12 months when health is on the line, a shelf full of optional supplements doesn’t stand a chance.

The medical world is, slowly, reaching the same conclusion about “more.” In reviews of polypharmacy — the steady accumulation of pills over time — specialists now warn that regimens tend to pile up by default, that a heavier pill count brings real “therapeutic burden” and lower adherence, and that more medicine is not automatically better.2

When the Form Defeats the Dose

There’s a second way complexity betrays you, and it hides inside those impressive numbers. A bigger dose in a form your body can’t readily absorb doesn’t necessarily deliver more benefit — it mostly leads to more being wasted. For example, in a systematic review of magnesium supplements, how much actually got absorbed depended on the form — with organic forms generally better absorbed than inorganic ones — and the proportion absorbed depended on the dose rather than holding steady.3

In other words, if your body absorbs, say 10% of a 100 mg dose (10 mg), taking 200 mg does not result in 20 mg of it being absorbed. In many cases, you just end up excreting a greater portion of it.

So, a supplement boasting an enormous milligram count can quietly underdeliver, while a smaller amount in a well-chosen form may provide “just enough” of what your body needs, resulting in less waste and lower cost. “More” on the label does not equate to “more” in your body. Chasing the bigger number is often chasing the wrong thing entirely.

Simplicity Is the Harder Achievement

Here’s what the “more” era misses: simplicity is the more difficult, more valuable accomplishment, precisely because it’s harder to reach. Real simplicity isn’t the absence of thought. Quite the contrary. It’s making sure the product is so well thought out and refined to the point where everything unnecessary has been stripped away and only what works remains.

This requires the supplement maker to identify the most effective form, the ideal dosage (just enough so that it doesn’t just end up as expensive urine), and the optimal delivery technology. In short, a simple product often requires more careful engineering.

That’s the standard we’re building toward, and it shapes every formulation decision we make going forward. Fewer things to take, not more, and supplement formats that fold into meals and beverages, to naturally support a food-centered foundation. For decades, I’ve promoted whole (ideally organic) food as the best source of nutrition, and that supplements are — as their name proclaims — additions to your diet when certain nutritional needs fall short.

A food-centered supplement regimen also works with how people actually live — busy, mobile, imperfect — instead of how a lab imagines we should live. Few of us can remember to take a handful of pills up to three times a day, and many have a hard time swallowing pills and capsules, which makes skipping doses all the more likely.

Simplicity solves most if not all of the problems that complexity created. A supplement routine you can keep is a supplement routine that can actually do something for you. The simpler it is, the more likely you are to stay consistent — and consistency is key. The most sophisticated formula in the world can improve nothing if you abandon it after a few weeks.

The Bottom Line

This is the direction we believe everything is heading, and it’s the direction we’ve chosen. Not bigger numbers or bigger bottles, but rather more bioavailable ingredients, in the ideal amounts, using the most effective delivery methods available. In some cases, that means powders instead of pills and capsules, and as I’ve explained previously, one of the biggest benefits of a well-designed powder supplement is that it becomes part of your meal.

You’re not choking down pills at a schedule that may or may not coincide with your food intake. You’re simply adding nutrition to the food you’re already eating anyway. It really doesn’t get much simpler than that. And that kind of simplicity is exactly what tends to translate into better long-term adherence.

It can also help switch people’s mental perception of their supplement regimen from one of disease (“I have to take these pills because I’m sick”) to one of health (“I’m optimizing my diet”).4 Considering how potent such perceptions can be, using food-centered supplement regimens is an easy way to ward against mindsets that undermine your health efforts.

Frequently Asked Questions

Q: Doesn’t “fewer ingredients” just mean I’m getting less for my money?

A: Not if it’s designed well. On the contrary, a supplement that is well-absorbed and has effective delivery can be taken in smaller doses, resulting in both less waste and greater value.

Q: Aren’t higher dosages typically better?

A: Not necessarily. How much your body absorbs depends heavily on the form a nutrient comes in, and a large dose in a poorly absorbed form can underdeliver while much of it goes to waste. A sensible amount in a well-chosen form is a more sensible and cost-effective strategy.

Q: Why is “simple” framed as the advance here, rather than cutting-edge ingredients?

A: Because if you want to improve people’s nutritional status through a supplement, the biggest problem is not the ingredients themselves but getting people to take it consistently. Complexity is what undermines that. Making the regimen really easy to adhere to — such as just sprinkling a scoop of nutritional powder on meals you’re eating anyway — is what helps a routine survive a busy schedule the most.

Q: Does a simpler supplement routine mean a less effective one?

A: No. It means the routine is built around what you’ll actually keep doing. An elaborate regimen you abandon in a month does far less for you than a simple one you sustain for years. Simplicity isn’t doing less for your health — it’s removing what was causing you to quit.

These statements have not been evaluated by the U.S. Food and Drug Administration.

This article is for general education. The products described are dietary supplements intended to support normal health and wellbeing as part of a food-first lifestyle. They are not a substitute for a varied diet, a healthy lifestyle, or the advice of your physician. If you are pregnant, nursing, taking medication, or managing a health condition, talk with your healthcare provider before beginning any supplement.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your health regimen.

Posted in Supplements | No Comments »

Posted by: | Posted on: September 12, 2026

Astaxanthin — A Therapeutic Agent in Cardiovascular Disease


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/09/12/astaxanthin-cardiovascular-benefits.aspx

Analysis by Dr. Joseph Mercola     September 12, 2026

astaxanthin cardiovascular benefits

Story at-a-glance

  • Heart disease develops quietly over years as blood vessels lose resilience under oxidative and inflammatory stress, long before symptoms appear
  • Astaxanthin supports heart health by protecting cell membranes and blood vessels from damage at the cellular level, rather than targeting surface-level markers alone
  • Research shows astaxanthin helps maintain flexible blood vessels, steady blood flow, and healthier heart tissue during periods of high stress or reduced oxygen
  • The benefits of astaxanthin depend on using natural sources and having it present before and during cardiovascular strain, not after damage has already occurred
  • Reducing oxidative stress through diet, improving sleep timing, and supporting natural vitamin D production all reinforce the same vascular repair pathways astaxanthin supports

Cardiovascular disease accounts for roughly 30% of all deaths worldwide.1 But before the dramatic event at the end of the timeline, there’s often a quiet biological drift that occurs. You rarely feel this shift as it unfolds. It typically shows up subtly in routine patterns, then compounds year after year until the damage becomes visible and difficult to reverse.
Much of that long arc traces back to how blood vessels respond to ongoing metabolic and environmental pressure. When the inner lining of your arteries loses resilience, circulation suffers, tissues receive less oxygen, and stress accumulates in places designed for constant flow.

Researchers have spent decades trying to interrupt this process, often focusing on single markers while missing the underlying drivers that keep the cycle active. That gap explains the renewed interest in compounds that work at the cellular level. Some nutrients influence how cells handle stress, repair themselves, and maintain structure under pressure.

When that foundation improves, downstream markers tend to follow. Astaxanthin, a naturally occurring red pigment found in certain marine foods and microalgae, stands out in this context because it supports the basic structures that protect cells under stress while reinforcing the systems that keep blood vessels and your heart functioning over time.

Astaxanthin Targets the Core Drivers of Heart Disease

A review published in the Journal of King Saud University examined astaxanthin as a nutraceutical for cardiovascular health, with a primary focus on atherosclerosis, blood pressure, lipid levels, and metabolic stress.2 The researchers evaluated how astaxanthin affects the biological processes that actually damage arteries over time, including oxidative stress and chronic inflammation, which directly affect your long-term heart risk.

The paper draws from animal research and human clinical trials involving adults with imbalanced blood fats, diabetes, high blood pressure, or elevated cardiovascular risk factors. These are the same categories many people fall into long before a diagnosis like heart attack or stroke appears on their chart.

• Astaxanthin consistently improved lipid patterns tied to plaque buildup — Across human trials summarized in the paper, astaxanthin supplementation lowered triglycerides and raised HDL cholesterol, often referred to as “good cholesterol,” because it helps remove excess cholesterol from artery walls.

• Improvements occurred without the tradeoffs seen with other antioxidants — Astaxanthin differs from beta-carotene and vitamin E, which failed to improve cardiovascular outcomes in large trials and, in some cases, worsened oxidative stress at higher doses. This comparison helps explain why astaxanthin shows benefits where other antioxidants fell short.

Why did vitamin E and beta-carotene fail where astaxanthin succeeds? Location matters. Most antioxidants float in the watery parts of cells or accumulate in fat stores, leaving membranes vulnerable. Astaxanthin is uniquely shaped to span the entire cell membrane, anchoring at both the inner and outer surfaces.

This positioning lets it intercept damage right where it starts — at the membrane itself. Additionally, high-dose vitamin E actually becomes a pro-oxidant under certain conditions, generating the very damage it’s supposed to prevent. Astaxanthin doesn’t share this liability.

• Blood vessel function improved alongside lipid changes — Animal studies reviewed in the paper showed reductions in systolic blood pressure and improved endothelial function. The endothelium is the thin inner lining of all your blood vessels — think of it as the “skin” inside your arteries. When it’s healthy, vessels relax easily, blood flows smoothly, and plaque has trouble gaining a foothold.

When it’s damaged, arteries stiffen, blood pressure rises, and the conditions for heart disease take hold. With astaxanthin, arteries stayed more flexible instead of stiffening under pressure. Most lipid and oxidative stress improvements appeared after four to 12 weeks of consistent supplementation.

• Astaxanthin works by neutralizing damaging molecules before they injure arteries — Oxidative stress involves unstable molecules that attack fats, proteins, and DNA inside your blood vessels. Think of oxidative stress like a fire spreading through dry brush. Unstable molecules called free radicals steal electrons from healthy cells, damaging them and triggering a chain reaction.

Astaxanthin acts like a fire break — it donates electrons freely, satisfying these unstable molecules before they damage your artery walls.

Unlike many antioxidants that float outside cells, astaxanthin spans the entire cell membrane, anchoring itself across the fatty layer that lines blood vessels. This positioning lets it shield vulnerable fats from oxidation, which slows plaque formation. Astaxanthin also activates a cellular switch that turns on your own antioxidant enzymes, including glutathione-related systems.

• Inflammation reduction plays a central role — Astaxanthin lowers inflammatory activity inside artery walls, slowing one of the earliest structural changes that leads to plaque formation. When immune cells absorb too much damaged cholesterol, they swell up and become trapped in artery walls — researchers call these bloated cells “foam cells” because of their bubbly appearance under a microscope.

These foam cells are the foundation of arterial plaque, the buildup that narrows arteries over time. Taken together, the paper shows that astaxanthin supports healthier cholesterol handling, steadier blood pressure, and stronger vessel walls through mechanisms that match how cardiovascular disease actually develops.

Why Form and Timing Matter for Real Cardiovascular Protection

A review published in the journal Marine Drugs set out to evaluate astaxanthin specifically through the lens of cardiovascular disease, with an emphasis on oxidative stress, inflammation, blood flow, and clot risk.3

Researchers studied what happens when blood flow to the heart stops and then suddenly returns — a situation doctors call ischemia-reperfusion injury. This mimics what occurs during a heart attack or heart surgery. Surprisingly, much of the damage happens not during the blockage itself, but when blood flow returns and floods oxygen-starved tissue. Astaxanthin showed remarkable protective effects during this key window.

• Astaxanthin protected the heart muscle during oxygen deprivation — In multiple animal studies summarized in the review, astaxanthin administration before an induced cardiac event limited the amount of heart tissue damaged during the period of extreme stress, helping preserve more healthy heart muscle.

• Protection increased with dose in controlled experimental settings — The review reports a clear dose-response relationship in several studies, where higher astaxanthin exposure led to greater reductions in tissue damage and oxidative markers.

Astaxanthin provided the strongest protection when present in tissues before vascular injury occurred. Human safety data summarized in the paper report no significant adverse effects across a wide dosing range, including effects on blood pressure, clotting, or liver markers.

• Blood flow dynamics improved independently of cholesterol changes — One unique finding emphasized in this paper is improved arterial blood flow and delayed clot formation in animal models, even when lipid levels were not the primary variable.

This finding separates astaxanthin from the cholesterol-focused approach that dominates conventional cardiology. Astaxanthin improves circulation directly, not just by changing lipid numbers on a lab report. In blood clot models, astaxanthin delayed vessel blockage without interfering with normal clotting needed for wound repair.

Why Astaxanthin Works Upstream of Cardiovascular Damage

Astaxanthin is a compound that strengthens heart cells, stabilizes blood vessels, and improves flow before damage escalates into clinical disease.4 Astaxanthin stands out because it targets oxidative stress and inflammation at their source, not downstream damage.

• Cell membranes remained intact under extreme oxidative pressure — Astaxanthin embeds across the lipid membrane, anchoring both ends and preventing breakdown when reactive molecules attack. This means your cells hold their shape instead of leaking and failing under stress.

Astaxanthin increased nitric oxide, the molecule that signals blood vessels to relax and widen. At the same time, it reduced peroxynitrite — a harmful compound formed when nitric oxide reacts with free radicals. Peroxynitrite stiffens arteries and damages tissue, so this dual action keeps vessels flexible while preventing collateral damage.

• Astaxanthin interrupts the inflammatory chain reaction in arteries — As explained in a review published in The American Journal of Cardiology, cardiovascular disease worsens when reactive oxygen and nitrogen species overwhelm blood vessels, activating inflammatory switches that drive endothelial dysfunction, plaque growth, and rhythm disturbances such as atrial fibrillation.5

Unlike vitamin E and beta-carotene, which failed in human trials, astaxanthin belongs to a class of oxygenated carotenoids that directly neutralize these reactive molecules and break destructive chain reactions before they damage vessel walls, making it a strong candidate for addressing a long-standing gap in cardiovascular treatment.

• Astaxanthin shows broad cardiovascular actions — A 2017 review published in Food & Function explains that astaxanthin influences multiple cardiovascular pathways at once, including oxidative stress control, inflammation reduction, blood pressure regulation, lipid handling, glucose balance, kidney protection, and plaque development.6

How to Address the Root Causes of Cardiovascular Damage

Many heart problems build over time through oxidative stress, chronic inflammation, damaged blood vessel lining, and poor cellular energy handling. Fixing those drivers first changes the trajectory, because lipid patterns, blood pressure, and circulation often improve as downstream effects. If you’re already seeing warning signs on labs, or you simply want stronger long-term protection, these steps keep the focus on causes, not symptoms.

1. Lower oxidative stress at the cellular level first — Oxidative damage injures artery walls and sets plaque processes in motion, and one of the biggest drivers is excess linoleic acid (LA) from seed oils. Many Americans consume far more LA than their tissues can safely handle, which fuels inflammation and mitochondrial dysfunction that pushes heart disease forward.

You lower that burden by cutting ultraprocessed foods and seed oils — keeping your LA intake below 5 grams per day. If you can get it under 2 grams, the benefit is even stronger.

To help measure your intake, I recommend you sign up for the Pax health platform, which contains the Seed Oil Sleuth. This feature helps calculate the LA in your food to a tenth of a gram. As oxidative stress drops, blood vessels regain flexibility instead of staying irritated and stiff.

Here’s where astaxanthin and seed oil reduction work together: Excess LA from seed oils makes your cell membranes more vulnerable to oxidation. Astaxanthin embeds in those same membranes and protects them. But if you’re constantly flooding your body with unstable fats, you’re fighting an uphill battle. Reducing seed oil intake lowers the oxidative burden, while astaxanthin reinforces the membranes you’re trying to protect.

2. Build blood vessel resilience — Reducing LA from seed oils and using more stable fats like grass fed butter, ghee, and tallow lowers oxidative stress in vessel walls, which helps preserve normal structure and function over time. Also support vessel flexibility with habits that reinforce circulation and relaxation.

Daily walking keeps blood moving across vessel walls, which signals them to stay elastic instead of stiff. Adequate magnesium intake also helps vessels relax appropriately rather than over-tightening under stress. When membranes are stable and vessels stay responsive, circulation improves naturally and the strain on artery walls drops.

3. If you use astaxanthin, choose the source that matches human nutrition — Astaxanthin occurs naturally in certain marine foods, including wild salmon, sardines, trout, shrimp, and krill, where it plays a protective role in those organisms. Including these foods regularly helps you obtain astaxanthin in a form your body already recognizes.

Krill oil offers a convenient way to obtain astaxanthin alongside omega-3 fats, since the astaxanthin in krill helps protect those delicate omega-3s from oxidation. This combination delivers cardiovascular benefits from multiple angles simultaneously.

If you decide to use an astaxanthin supplement, I strongly recommend products made from the Haematococcus pluvialis microalgae, not versions produced from petrochemicals or genetically engineered yeast. This keeps your intake aligned with the forms studied in cardiovascular research and avoids unnecessary exposures tied to synthetic production, while preserving the benefit profile linked to natural astaxanthin.

Most human studies showing cardiovascular benefits used doses between 4 and 12 milligrams (mg) daily of natural astaxanthin from Haematococcus pluvialis. Higher doses (up to 24 mg) have been studied safely, but the sweet spot for most people appears to be 8 to 12 mg daily, taken with a fat-containing meal to enhance absorption.

4. Use astaxanthin strategically during periods of higher cardiovascular stress — Astaxanthin provides the most value when oxidative and inflammatory stress rise. Intense exercise, emotional stress, frequent travel, and disrupted sleep all place extra strain on blood vessels and heart tissue. These are the moments when oxidative damage accumulates fastest — and when astaxanthin’s protective effects matter most.

Using astaxanthin consistently during these higher-demand phases helps reinforce cellular defenses when damage is most likely to occur. This shifts astaxanthin from a passive supplement to an active support tool matched to real-world stress patterns.

5. Restore circadian alignment with sunlight, vitamin D, and proper sleep — Your blood vessels follow a circadian rhythm. For instance, untreated sleep apnea and disrupted sleep cause a sharp nighttime drop in blood vessel function, increasing vulnerability to heart attacks and other cardiac events.7 Supporting healthy sleep timing and morning light exposure helps stabilize that rhythm.

As you begin to eliminate seed oils, avoiding harsh midday sun for at least six months gives your skin time to clear stored LA, which improves sun tolerance and lowers burn risk during peak midday exposure. As that process completes, gradual midday sun exposure supports natural vitamin D production, reinforcing vascular function, energy balance, and overnight repair.

FAQs About Astaxanthin and Heart Disease

Q: Why does cardiovascular disease develop so gradually?

A: Cardiovascular disease usually develops over many years through ongoing stress on blood vessels. Factors such as oxidative stress, chronic inflammation, and impaired cellular energy slowly weaken the artery lining, reducing circulation efficiency long before noticeable symptoms appear.

Q: What makes astaxanthin different from other antioxidants studied for heart health?

A: Astaxanthin acts at the cellular level, protecting cell membranes and interrupting damaging oxidative and inflammatory processes before they escalate. Unlike antioxidants that failed in large trials, astaxanthin works upstream by stabilizing cells and supporting normal vessel function under stress.

Q: How does astaxanthin support blood vessel and heart function?

A: Research shows astaxanthin helps preserve flexible blood vessels, supports healthy blood flow, and protects heart tissue during periods of reduced oxygen or increased stress. These effects align with how cardiovascular damage actually develops, rather than focusing on isolated markers alone.

Q: Why does the form and timing of astaxanthin matter?

A: The benefits of astaxanthin depend on using biologically appropriate forms and having it present during periods of higher oxidative or inflammatory stress. Natural sources and consistent use during demanding phases, such as intense exercise or disrupted sleep, align best with the research findings.

Q: How do lifestyle factors like diet, sleep, and sunlight fit into cardiovascular protection?

A: Lowering oxidative stress through diet, supporting daily circulation with movement, and maintaining healthy circadian rhythms all reinforce blood vessel repair. Proper sleep timing and regular sunlight exposure support vascular function and vitamin D production, helping protect your heart.

Q: How much astaxanthin should I take, and when?

A: Most research showing cardiovascular benefits used 4 to 12 mg daily of natural astaxanthin. Because astaxanthin is fat-soluble, taking it with a meal containing healthy fats (like grass fed butter or pastured eggs) improves absorption. Consistency matters more than timing — daily use builds tissue levels over weeks, providing ongoing protection rather than acute effects.

Posted in Cardiovascular, Food, Heart, Inflammation, Linoleic Acid, Supplements | No Comments »

Posted by: | Posted on: August 12, 2026

Why Pills Don’t Fit Modern Life: The Burden of Too Many Capsules


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/08/11/capsule-burden.aspx

Analysis by Dr. Joseph Mercola     August 11, 2026

capsule burden

Story at-a-glance

  • The morning handful of capsules is a holdover from a slower era — nearly every other part of daily life has been simplified, but the pill routine never was
  • The sheer number of capsules required for some nutritional supplement regimens is itself a barrier to long-term adherence
  • Difficulty swallowing pills is far more common than most people assume, and larger pills are dramatically harder to get down — a common reason for why so many people fail to maintain their supplement routines
  • Multiple daily schedules and travel make a pill or capsule routine fragile; it’s often the first thing to fall by the wayside on a busy or disrupted day
  • For suitable ingredients, reformulating capsules into a powder that can be mixed into food or beverages removes most of that friction, thereby giving you the best chance of staying consistent in the long term

The handful-of-pills routine belongs to another era. Picture the morning ritual the supplement world quietly expects of you: a little assembly line of bottles on the counter, the careful counting, the palm filling up with capsules of different sizes and colors, and then the part nobody enjoys — getting the whole mouthful down with a gulp of water, hoping the big one doesn’t catch on the way.

We have all just accepted this. But step back and it’s a strangely outdated way to take care of yourself. Almost every other part of modern life has been simplified to fit the way people actually live. Yet the standard supplement routine has barely changed: bottles, capsules, timing, water, swallowing, sorting, and refills. The rest of life moved toward convenience. Supplements stayed stuck in the pillbox.

The Pill Routine Takes More Than It Seems

The capsule routine looks simple, but it quietly asks a great deal — and each demand is a place where the routine can break. Start with the count. The sheer number of pills is a barrier all by itself. In a multicenter study of older adults managing several conditions, three-quarters reported a high treatment burden and more than two-thirds did not take their medications as directed — and the strongest drivers of that burden were the complexity of the regimen and the number of pills to take.1

It’s a consistent finding: the more pill-heavy and more complex the routine, the more reliably people abandon it.

Then there’s the swallowing itself, which is a real barrier and a surprisingly common one. In a survey of outpatients picking up their prescriptions, more than 40% reported difficulty swallowing pills, and the authors noted that international estimates run anywhere from roughly 29% to 55% of adults, with about a third saying the trouble had caused them to miss doses.2

And it gets worse as the pills get bigger. When researchers analyzed what makes a tablet or capsule hard to get down, oversized pills stood out as by far the strongest factor, raising the odds of difficulty roughly tenfold.3 Anyone who has hesitated before the largest capsule in the lineup already knows this. Even people who don’t think of themselves as having trouble quietly dread the big one.

Now stack on the logistics. Two or three different schedules a day turn a simple act of self-care into a small management job — this bottle in the morning, that one with lunch, another at night. Travel makes it worse: the bottles are bulky, the routine is fragile, and taking a pile of capsules is easily forgotten on a busy trip. None of this fits modern life. It fits a slower, simpler era that no longer exists for most of us.

So we asked an obvious question that the industry mostly steps around. What if you didn’t have to choke down a fistful of capsules at all? What if the format itself were built around how people actually live — easier to take, and easy to keep up even when the day is a mess?

A Format Built for Real Life

That’s the direction we’re going — away from the pill pile and toward formats that are simpler to use and supports a food-first ideology. In practice, that means taking the ingredients suited to it and reformulating them out of capsules and into a clean powder that can be stirred into a glass of water, a smoothie, a bowl of yogurt or oatmeal, or sprinkled on whatever else you’re already eating. The supplement routine stops being a separate event you have to remember and becomes part of a meal you were having anyway.

Not every ingredient can be turned into a powder. Some are needed in doses so small they’re better measured into a small pill; some taste or keep better sealed away; some contain oils that call for a softgel. The goal isn’t to abolish pills or capsules from our product line — it’s to stop reaching for it by default, and to use a powder wherever the ingredient genuinely allows it.

For the many that do, the change can be dramatic: nothing to count, nothing to choke down, no big capsule to dread, and no bulky bottles to pack when you travel. All of that can translate into a routine that doesn’t collapse the moment your schedule does.

Why the Format Is the Whole Point

The point isn’t novelty for its own sake. It’s that the format chosen can significantly affect adherence — and consistency is what ultimately makes the difference, because a supplement only does something if you actually take it. A supplement that’s pleasant and effortless to take gets taken. A handful of capsules that feels like a chore gets skipped, then forgotten at the back of a shelf.

This is the thread that runs through everything we’ve been saying in this series. The best formula in the world is worthless if it ends up in your cabinet instead of in you. Modern life is busy, mobile, and unpredictable. Your nutrition should be built for that life, not for the imaginary, unhurried one the capsule routine was designed around.

The Bottom Line

While the fistful of capsules strategy is convenient for those who make and ship supplements, it quietly works against the person trying to stay consistent. For the ingredients that allow it, a clean powder you mix into food or a drink removes most of the friction that leads to skipped doses and dropped regimens. Once a routine is built around the life you actually live, consistency stops being a losing battle.

Frequently Asked Questions

Q: What’s wrong with capsules?

A: Nothing, for the right ingredients. Capsules protect fragile compounds and allow precise small doses. The problem is using them by default for everything, including ingredients that would be far easier to take as a powder. The cost shows up as friction: counting pills, swallowing, dreading the big one, and keeping multiple schedules straight. That friction is the main reason supplement routines fall apart.

Q: Is difficulty swallowing pills really that common?

A: More common than most people think. In one survey of outpatients, more than 40% reported difficulty swallowing pills, with international estimates ranging from roughly a quarter to over half of adults — and a meaningful share said it had caused them to miss doses. Larger pills are by far the hardest to get down. Many people who’d never call it a “problem” still quietly dread the biggest capsule in the pile.

Q: How does a powder improve adherence to a supplement regimen?

A: A powder you mix into food or a beverage removes the swallowing barrier entirely and folds the supplement into something you already do — eating. There’s nothing to count out, nothing to choke down. For suitable ingredients, it turns the most-skipped part of the day into one effortless motion.

Q: Does switching from a capsule to a powder mean a weaker product?

A: No. It means the product is designed around what you’ll actually keep doing. The format largely determines consistency, and consistency is what makes a supplement worth taking at all. A simpler routine you can sustain for years will do far more for you than an elaborate one you abandon in a month.

These statements have not been evaluated by the U.S. Food and Drug Administration.

This article is for general education. The products described are dietary supplements intended to support normal health and wellbeing as part of a food-first lifestyle. They are not a substitute for a varied diet, a healthy lifestyle, or the advice of your physician. If you are pregnant, nursing, taking medication, or managing a health condition, talk with your healthcare provider before beginning any supplement.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your health regimen.

Posted in Supplements | No Comments »

Posted by: | Posted on: August 1, 2026

Vitamin K Helps Lower Mortality Risk in People with Fatty Liver Disease


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/07/25/vitamin-k-fatty-liver-disease.aspx

Analysis by Dr. Joseph Mercola     July 25, 2026

vitamin k fatty liver disease

Story at-a-glance

  • Fatty liver disease affects 1 in 4 adults globally and can silently progress to liver failure, internal bleeding, or cancer without early warning signs
  • Higher vitamin K intake from food was linked to a 19% lower risk of death in people with fatty liver disease, according to long-term research
  • Even moderate vitamin K intake — below 121 micrograms per day — was linked to a 33% drop in death risk, especially in those not taking supplements
  • Obese individuals and older adults showed less benefit from vitamin K, likely due to reduced utilization or nutrient trapping in fat tissue with age and body weight
  • A major cause of fatty liver disease is excess linoleic acid (LA) and low choline intake, which together damage mitochondria, impair fat metabolism, and promote dangerous fat buildup in the liver

Fatty liver disease is fast becoming an epidemic, with one-fourth of adults globally now struggling with it.1 Many are unaware that they have this condition until severe symptoms manifest. If not addressed immediately, it could lead to liver failure, internal bleeding, or liver cancer.

The good news is that fatty liver disease is preventable and that you actually have more control over your liver health than you think. An easy way to protect your liver health is by consuming a nutritious, well-balanced diet. One of the nutrients that will significantly help is vitamin K — studies have provided supporting evidence on this.

Moderate Vitamin K Intake Lowers Risk of Death in People with Fatty Liver Disease

Fatty liver disease has undergone a major conceptual shift, both in how it’s diagnosed and in how its root causes are understood. Today, the term metabolic dysfunction-associated steatotic liver disease (MASLD) has replaced older labels like nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

I prefer to describe this condition as simply “fatty liver disease.” The additional attribution to cause is just medical jargon that provides no additional information about the condition itself and all three are synonyms for fatty liver disease.

A study published in Scientific Reports investigated whether vitamin K intake affects the survival time of people with fatty liver disease. The researchers analyzed health and nutrition data from 7,857 adults diagnosed with fatty liver disease using U.S. National Health and Nutrition Examination Survey (NHANES) surveys between 2005 and 2018.2

• Researchers investigated whether this specific nutrient plays a role in improving fatty liver disease outcomes — They tracked these participants’ diets and survival outcomes for up to 15 years to determine if there was a relationship between how much vitamin K people ate and their risk of dying from any cause.

Among this group, 842 deaths were recorded during the study period — giving researchers enough data to draw firm conclusions.

• Here’s what they found — People who ate more vitamin K from foods were significantly less likely to die over the follow-up period. Specifically, every one-unit increase in vitamin K intake was linked to a 19% lower risk of dying.

• Moderate intake reduced the risk of dying — What’s even more impressive is that for those consuming less than 121 micrograms (mcg) of vitamin K per day, each step up in intake was linked to a 33% drop in the risk of death. Even after adjusting for different external factors like smoking, alcohol use, body mass index (BMI), and supplement intake, the link between moderate vitamin K consumption and lower mortality risk remained strong.

• Interestingly, the researchers explored why consuming too much vitamin K didn’t provide added benefits — One explanation is that vitamin K shares a metabolic pathway with vitamin E, and high intake of one might interfere with the other. Both nutrients are processed by the same liver enzyme (CYP4F2), and excessive vitamin E has been shown to reduce vitamin K levels in animal studies.

In this study, when the researchers adjusted for vitamin E intake, the protective effect of vitamin K slightly weakened — suggesting some overlap or competition between the two.

Getting Enough Vitamin K from Your Diet Significantly Reduces Your Risk of Fatty Liver Disease

While the featured study shows how vitamin K is beneficial for people already with fatty liver disease, an earlier study published in the Frontiers in Nutrition shows that getting enough of this nutrient from your diet may help avoid the onset of this disease.3

The researchers analyzed data from 3,571 adults across the U.S. using NHANES surveys from 2017 to 2018 to identify whether people with higher vitamin K intake had lower odds of having fatty liver disease — and whether that was different in people who relied on food alone versus those who used dietary supplements.

• People with fatty liver disease consistently ate less vitamin K than those without it — On average, the people who developed fatty liver disease consumed about 123 mcg daily, while the healthy group consumed around 145 mcg per day.

After the researchers adjusted for lifestyle, metabolic, and dietary factors, the data still showed the same results — having more vitamin K in your diet leads to a less fatty liver.

• Vitamin K from foods provided the best benefits — The study found that the protective effects of vitamin K were strongest in people who got this nutrient from their diet. When the researchers looked specifically at people who did not use supplements, the protective link between vitamin K and lower liver fat remained strong and statistically significant.

But among supplement users, the association lost its strength once other factors — like exercise, calorie intake, or metabolic diseases — were accounted for. Hence, the study shows that eating vitamin K-rich foods provided more liver-protective benefits than supplementation.

• The protective effects were consistent across most major groups, except for two — the elderly and obese individuals — One possible explanation is that vitamin K is fat-soluble and gets sequestered in fat tissue. That means obese individuals store vitamin K in fat rather than use it for liver protection.

Why Does Vitamin K Have Beneficial Effects for Fatty Liver Disease?

To understand why vitamin K is so effective, these two studies highlighted several biological mechanisms.4,5

• Vitamin K is essential for activating the matrix Gla protein (MGP) — this protein prevents calcium from hardening in soft tissues. In fatty liver disease, where chronic inflammation accelerates vascular calcification and insulin resistance, this function is especially important. By ensuring MGP is fully activated, vitamin K helps protect both your liver and blood vessels from long-term damage.

• It reduces inflammation, a key driver of fatty liver disease progression — Vitamin K does this by blocking a signaling molecule called NF-κB, which fuels the release of damaging cytokines like IL-6 and TNF-α. This matters because unchecked inflammation pushes fatty liver disease toward more advanced stages, like fibrosis and cancer. By inhibiting this inflammatory cascade, vitamin K helps keep your liver from progressing to those advanced and life-threatening stages.

• Vitamin K supports healthy insulin function — Insulin resistance is one of the primary root causes of fat accumulation in the liver. When your cells ignore insulin, your body stores more fat in the liver — and damage follows. Vitamin K helps restore insulin sensitivity by supporting proper insulin receptor activity. This improves how your body handles glucose and fat, which in turn slows down or even reverses fat accumulation in the liver.

• Vitamin K protects your liver on a cellular level — It helps reduce oxidative stress and prevent ferroptosis, a form of cell death triggered by fat-based toxins and free radicals that build up in the liver. Vitamin K interferes with this destructive process, acting like a molecular shield for liver cells.

It also activates a protein called Gas6, which in turn boosts AMP-activated protein kinase (AMPK), an enzyme that governs fat burning and insulin sensitivity. In short, vitamin K signals your liver to burn fat more efficiently and store less of it — helping reverse the key metabolic damage behind fatty liver disease.

The 2 Types of Vitamin K

Vitamin K exists in two forms — vitamin K1 (phylloquinone) and vitamin K2 (menaquinones).6 These two forms are differentiated through their sources and their functions in your body:

• Vitamin K1 — Derived from plant sources like vegetables, this nutrient facilitates blood coagulation, a vital process that prevents excessive bleeding when injuries occur.

• Vitamin K2 — This plays a more significant role in bone and cardiovascular health, guiding calcium to your bones and away from your arteries. Its primary sources are animal products and fermented foods. In studies, this is the type that protects against fatty liver disease.7

• Vitamin K2 exists in several subforms — These are designated as menaquinone-4 (MK-4) through MK-13. MK-7 through MK-13 are primarily produced by bacterial fermentation in your gut, but they’re also found in fermented foods

• Vitamin K2 is superior, studies show — While both forms of vitamin K are indispensable, there are studies showing that vitamin K2 has certain advantages over K1,8 particularly in terms of absorption, distribution, and overall impact on your body. I recommend reading “Vitamin K1 vs. K2 — Understanding Their Distinct Roles in Your Health” for more information on this topic.

What Are the Best Food Sources of Vitamin K2?

As the second featured study mentioned, ensuring adequate intake of vitamin K particularly through K2-rich foods is the best way to reap the benefits of this nutrient. These include:9

• High-quality animal products — Opt for grass fed and pasture-raised animal products such as tallow and organ meats like liver.

• Certain cheeses like Gouda and Brie — These have high K2 content. Choose cheese made with animal rennet instead of GMO alternatives.

• Fermented foods — Natto, a traditional fermented soybean product, boasts the highest concentration of highly absorbable MK-7 vitamin K2.

• Egg yolks — While egg yolks are classified as an animal product, I do believe they deserve a special mention, as they are among the highest dietary sources of MK-4, a vital form of vitamin K2 that plays a crucial role in bone health, cardiovascular function, and calcium regulation. Plus, egg yolks are a rich source of choline, another nutrient that plays a significant role in liver health (more on this below).

You just need to be careful about your egg sources as most commercial egg sources — even free-range organic — have high levels of polyunsaturated fats (PUF) levels as they are fed grains like soy and corn. Ideally, chickens should be fed rice, barley and split peas. I personally eat six egg yolks a day from chickens who are fed this and have 80% less linoleic acid (LA) than regular chickens.

Below is a comprehensive overview of egg yolks as a top source of MK-4, along with additional dietary sources and considerations.

nutrient comparison in egg yolks vs other sources

However, I do understand that there are circumstances where it may be difficult to obtain this nutrient from dietary sources. In this case, I recommend adding a high-quality MK-7 vitamin K2 supplement to your daily regimen.

A Deadly Combination That Leads to Fatty Liver Disease — Excessive Linoleic Acid and Choline Deficiency

Going back to the topic of fatty liver disease, I believe that one of the most significant factors contributing to its increasing rates today is the excessive LA in our modern diet and how it disrupts cellular health. Pair it with choline deficiency, and you end up with a vicious cycle leading to fatty liver disease.

I’ve written a paper on this topic, which is still pending peer-review, however, you can download and read a simplified version here. I’ve also highlighted the most significant points below.

Download PDF of the Simplified Paper

• A key factor leading to fatty liver disease is mitochondrial dysfunction — Ethanol (found in alcohol) and LA are the two most significant drivers of fatty liver disease in our modern diets; they produce toxic aldehyde byproducts when metabolized in the liver. Ethanol is converted into acetaldehyde, while LA breaks down into 4-hydroxynonenal (4-HNE), both of which are highly reactive and damaging to mitochondria. These aldehydes bind to proteins, phospholipids, and mitochondrial DNA, impairing oxidative phosphorylation and reducing the liver’s ability to generate ATP. Over time, this impairs the liver’s capacity to oxidize fats, allowing them to accumulate inside your liver cells.

• When the aldehydes damage the mitochondria’s protective membranes, the inner structure starts to break down — This hampers their energy-making process, reducing production of ATP (your cells’ main energy source) and causing more reactive oxygen species (ROS) to leak out, which adds to oxidative stress.

As the mitochondria start sending distress signals, it activates immune responses, triggering inflammation in the liver. This worsens fatty liver disease — from simple fat buildup, it progresses to serious conditions like fibrosis or liver cirrhosis.

• How does choline help? Choline, an essential nutrient that plays a pivotal role in liver function, mitochondrial performance, and membrane integrity, acts by crossing the intestinal wall and entering the bloodstream. It is then transformed into phosphatidylcholine (PC) through a multi-step process called the CDP-choline pathway. The end result of this process is phosphatidylcholine (PC) — this is the form your liver uses to build membranes and carry fat out of the cell.

• Choline’s roles go beyond liver function — Once absorbed into cells, choline enters a network of metabolic routes that support brain signaling, gene regulation, fat metabolism, and bile composition. It plays a role in fetal development and infant brain growth, nervous system health, and cardiovascular health.

Protect Yourself from Fatty Liver Disease with These Strategies

As these findings show, it’s clear that addressing fatty liver disease starts with making changes to your diet. Certain key nutrients — combined with healthy lifestyle changes — will help protect you from the onset of this disease and minimize its damage. Here are my recommended strategies.

1. Improve your diet — Focus your meals on whole, unprocessed foods, especially vegetables, fruits, lean proteins, and healthy carbohydrates. I also recommend consuming foods high in vitamin K and choline, while removing ultraprocessed foods, especially seed oils that are high in linoleic acid.

2. Consider citicoline supplementation — Choline is abundant in food sources like beef liver, egg yolks, and raw milk. However, if you’re not getting enough, taking a high-quality supplement will help boost your intake.

I recommend citicoline because most forms of choline supplements have poor availability. Citicoline is the immediate precursor for the synthesis of phosphatidylcholine, and increased intake helps your fat to be transported out of your liver. Formulations differ depending on the manufacturer, ranging from 500 to 2,500 mg per day. To find out your ideal dose, consult with your health care provider because choline toxicity, while rare, is a real condition.

3. Manage your weight — Excess body weight is a culprit in fatty liver development — as one of the studies mentioned, vitamin K is fat-soluble and could be sequestered into fat tissue instead of being used by your liver. Losing even a modest amount — around 7% to 10% of your total body weight — will have dramatic benefits.

4. Stay physically active — Exercise is one of the best things you can do for your health, as it helps your body burn off excess fat stores, especially around your liver, and boosts insulin sensitivity, directly reducing the inflammatory cycle caused by fatty liver disease. Aim for at least 30 minutes of moderate-intensity activity most days of the week, such as brisk walking, cycling, or swimming.

5. Address underlying metabolic imbalances — If you’re diabetic, pre-diabetic, or insulin-resistant, improving your blood sugar control is essential. Pay close attention to your carbohydrate intake, choosing complex carbs (like white rice) over simple sugars.

Frequently Asked Questions (FAQs) About Vitamin K and Fatty Liver Disease

Q: How does vitamin K help protect against fatty liver disease?

A: Vitamin K supports liver health by reducing inflammation, improving insulin sensitivity, and preventing fat-related cell damage. It also activates proteins that help prevent scarring and calcification in liver tissue, slowing or reversing disease progression.

Q: Is vitamin K from food better than supplements for liver protection?

A: Yes. Research shows that people who got vitamin K from food had better protection against fatty liver disease and lower risk of death. Whole foods appear to offer more consistent benefits than synthetic forms.

Q: What makes food-based vitamin K more effective than supplements?

A: Food-based vitamin K is absorbed and used by the body more effectively, especially when combined with other nutrients naturally present in whole foods. Supplements may not deliver the same benefits due to differences in metabolism.

Q: Why didn’t obese individuals and older adults benefit as much from vitamin K?

A: Vitamin K is fat-soluble and may get trapped in body fat, especially in obesity. In older adults, metabolic changes might reduce how well their bodies use the vitamin, limiting its liver-protective effects.

Q: What other nutrients affect fatty liver disease risk?

A: Excess linoleic acid (from seed oils) and choline deficiency are a harmful combination that worsens liver damage. Choline helps export fat out of liver cells, while linoleic acid drives mitochondrial injury. Addressing both is key to recovery.

Posted in Choline, Food, Linoleic Acid, Liver, Supplements | No Comments »

Posted by: | Posted on: July 27, 2026

What Is Akkermansia — A Keystone Microbe in Your Gut (An Interview with Dr. Colleen Cutcliffe)


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/07/26/akkermansia-microbiome-health-impacts.aspx

Analysis by Dr. Joseph Mercola July 26, 2026

Story at-a-glance
  • The composition of your gut microbiome may have an encompassing influence on your health, including metabolic, neurological, and digestive function
  • The diversity of your microbiome varies depending on your diet, age, location, and other factors. Age-related loss of diversity may be a meaningful contributor to age-related changes in function and the onset of chronic conditions
  • In conventional antibiotic treatment, roughly 20% to 30% of Clostridium difficile cases recur after initial therapy, and severe or refractory cases carry meaningful mortality risk. Fecal microbiota transplant (FMT) has been reported in some trials to have cure rates around 80% to 90%
  • Akkermansia muciniphila is among the gut bacteria most studied as a key contributor to microbiome health
  • Reduced integrity of the mucin layer has been associated with what researchers describe as leaky gut syndrome. Akkermansia muciniphila is among the strains most closely studied for its interaction with the mucin layer

The video above features an interview with Dr. Colleen Cutcliffe, a molecular biology scientist and the CEO and cofounder of Pendulum, a company creating microbiome products. This interview was done as part of my early explorations into the obligate anaerobe microbiome field. I was particularly drawn to Dr. Cutcliffe’s work with Akkermansia.

How Your Gut Microbiome May Influence Health

Yogurt and probiotics have been popular for decades, but what really catalyzed interest in the human microbiome was the advent of DNA sequencing. This allowed scientists to begin identifying and differentiating the various microorganisms found in the human body — along with the introduction of fecal transplants. As explained by Cutcliffe:

“One of the interesting things that people realized was that the gut microbiome has the ability to change symptoms and change diseases. This discovery largely came about as a result of research into fecal microbiome transplants (FMT), where you take feces from a healthy person and place it into a sick one.

That may sound really disgusting until you know that it actually has incredible medical value. Some of the first places where these fecal microbiome transplants were used were for treating Clostridium difficile infections.

[When] you take an antibiotic, it kills off most of the bacteria in your gut. This strain called Clostridium difficile now has no competitors, so it can start to divide and replicate. When it gets to high levels, it becomes extremely toxic and ultimately fatal.

What they found was that if you transplanted stool into these people who were suffering from this infection, and you basically inundated the microbiome with all these new competitors and were able to swamp out [C. difficile], you could save a person’s life better than the therapies that were being used.”

In conventional antibiotic treatment of C. difficile, recurrence has been reported in roughly 20% to 30% of patients, with materially higher rates in severe or refractory cases. FMT cure rates reported in published trials vary widely, but are generally in the range of 80% to 90%. Despite these positive outcomes, FMT has still not become standard of care for C. difficile infections.

Small, early-stage studies have explored FMT in other contexts as well, including metabolic, gastrointestinal, and neurological conditions, though the evidence base is preliminary and quality varies considerably. That said, a key, open question is: which of the many microorganisms transferred are responsible for the observed effects?

Potential Safety Concerns of FMT

Important safety questions remain, as there’s much we do not yet know about the microbiome. For example, a pathogenic microorganism that has not yet been fully characterized could be inadvertently transferred via FMT.

Your microbiome is made up not just of bacteria, but also viruses, bacteriophages, fungi, and yeast, and we don’t yet understand exactly how all these organisms affect human health, let alone their interactions.

What’s more, your microbiome changes depending on location, so the microbiome of someone living in the U.S. will not be the same as that of someone living in India or Norway. The reason for this is because your microbiome is heavily influenced by diet, medical interventions, toxic exposures, and the natural environment, all of which vary from one person and location to the next.

To address some of these issues, companies are now working on developing manufacturing processes to survey and clean up the stool, and then deliver the final product in pill form.

“There are several companies out there that are doing this kind of an intervention, which I think is a little bit safer than the pure stool,” Cutcliffe says.

Surveying the Human Gut Microbiome

Many scientists are now working on surveying the gut microbiome. It started with the American Gut Project, where academics from around the U.S. surveyed all the different parts of the human microbiome, not just the gut microbiome but also the microbiome in your nasal passages and ears, and on your skin.

“They’re trying to understand, what does the population look like? One of the really interesting high-level themes that’s come out is that the more so-called advanced or industrialized a country is, the less diverse their microbiome.

You can go into populations in the rainforest, where they’ve been relatively untouched by Western civilization, and they have incredibly diverse microbiomes, meaning they have lots and lots of different types of strains that are doing lots and lots of different activities.

As you get to more industrialized countries, like the United States, we have a less diverse population of strains. One of the other interesting things is that if you look at an individual as they age, younger people have a more diverse microbiome compared to people who are older.

So, one of the overriding theories is that this loss of diversity represents a loss in functionality that is tied to reduced health, and potentially even perpetuating disease. And so, can you give these [microorganisms] back and help people improve disease?

For example, as people age, many experience new food sensitivities that they didn’t used to have, or they experience more GI distress more frequently than they used to. Unfortunately, many feel like there’s nothing they can do about that; that it’s just part of aging. But that’s not true. It’s [due to] this depletion in the microbiome, and there is something that you can do about it.

Ultimately, all of these guys are housed inside your body, so you are in complete control over who’s living, who’s dying, who you’re feeding through the foods that you’re eating. You can get to a point where you’re sensitive to these foods because you’ve lost [certain] strains in your gut, but you can replenish them and get back to eating those foods.”

The traditional strategy has been to improve your diet, eat more real food. This will work over time, but it’s a slow process that can take many months. A more efficient strategy would be to repopulate your gut with essential strains in addition to the appropriate dietary changes. The question is which strains matter most.

What Is Akkermansia and What Does It Do?

Since it was first described 20 years ago, considerable research has been published on Akkermansia and its possible roles in health. Much of Cutcliffe’s work has focused on this bacterium, given the breadth of research interest in it. “Akkermansia is quickly becoming known as a keystone strain in your microbiome,” she states.

While the microbiome is an ecosystem of many strains, certain strains like Akkermansia appear to play disproportionate roles. Akkermansia was first described in 2004 by Derrien and colleagues in a study published in the International Journal of Systematic and Evolutionary Microbiology.1 Subsequent research has examined associations between Akkermansia levels and metabolic markers, including body weight. Here are examples:

• Associations with glycemic status — Observational research has linked low or absent Akkermansia levels to populations with prediabetes and Type 2 diabetes.

• Interacts with the gut mucin layer — Researchers have found through both human and animal studies that Akkermansia is a key strain associated with maintenance of the mucin layer.2 Cutcliffe describes it as “the ‘glue’ that keeps your gut lining strong.” She further explains:

“You have these epithelial cells and the junctions between them are held together by glue, which is called mucin. When the mucin layer gets too thin, you lose those tight junctions, and that’s where you can start to get things moving across that boundary that are not supposed to move across it.

So, it’s important to have a strong gut lining and Akkermansia is one of the strains we know of that is there at the mucin layer, both interacting with and helping regulate that layer. That’s why it’s of interest in research on a range of conditions.”

• Akkermansia and the gut-immune axis — Researchers have hypothesized that reduced mucin-layer integrity may contribute to immune dysregulation in some contexts. This remains an active area of investigation. Akkermansia helps support mucin-layer integrity, which in turn may influence what crosses the intestinal barrier.

• Akkermansia and gut-barrier function — When the mucin layer is thin, larger molecules may cross more readily. Some research suggests that supporting Akkermansia levels may help support mucin-layer function and, by extension, gut-barrier integrity.

How Akkermansia May Influence GLP-1 Signaling

Drug companies are now promoting injectable glucagon-like peptide 1 (GLP-1) agonists for weight loss, and these drugs can have troublesome side effects. Researchers have noted overlap between GLP-1 agonist activity and pathways involving Akkermansia, though the mechanisms and contexts differ substantially. Cutcliffe explains how Akkermansia is thought to influence GLP-1:

“When it was observed that people with Type 2 diabetes or prediabetes were low in Akkermansia, it was believed that it was because of this mucin deficiency. But as people started to study Akkermansia more, and the microbiome in general, what’s become clear is that it’s a lot more direct than just the mucin layer.

What happens in your body naturally, if you’ve got all the right microbes, is that you eat a meal, your microbiome metabolizes that food and generates postbiotics [excretions from beneficial bacteria] like butyrate [and] a protein called P9. Some of these postbiotics then signal your body to produce GLP-1.

All that signaling is happening from the microbiome directly to the L cells. And so you eat a meal, your microbiome digests them, these postbiotics get created and tell your L cells, ‘Hey, go produce GLP-1,’ and then you get a spike in GLP-1 in your body.

GLP-1 stimulates your body, too. It says, ‘We’ve got to metabolize the sugar in the bloodstream, release insulin.’ It also signals to your brain, ‘We just ate, we’re full, we don’t need to eat again.’ After a period of time, GLP-1 goes down — until the next time you eat a meal. Then it spikes again.

So, that’s the natural way of things. There are only two strains that have been published, to date, that have been shown to be able to stimulate L cells to produce GLP-1, and one of them is Akkermansia. It actually secretes three different [postbiotics] that stimulate L cells to produce GLP-1.

So, what’s been found is that if you are low or missing Akkermansia, your body is not naturally producing as much GLP-1 as it’s supposed to be. By giving people back Akkermansia, you can now have these physiological benefits of reducing A1C and lowering blood glucose spikes.

To be clear, the natural GLP-1 you produce is different from the drug. The drug is a mimic. It’s an analog. It looks like GLP-1. It gets injected into the bloodstream directly, which means that rather than the natural spike after you eat [followed by a decline], the [drug] is keeping those levels really high all the time.

So, this signaling of ‘we got to metabolize sugar in the blood and we’re full, we just ate’ is going on constantly. That’s why people experience these incredible, amazing overnight effects because that’s how those drugs are working. But if you actually have the right microbes, you can generate your body’s natural GLP-1 and get back into this natural cycle.”

Akkermansia and Food Cravings — Emerging Research

Early research has examined whether Akkermansia supplementation may influence food cravings, with some studies reporting effects on sugar-related cravings.

“What that tells us is that your microbiome has the ability to change your cravings, and that can really guide you to better eating habits and then, in turn, replenish the good microbes,” Cutcliffe says. “So, you end up being on a good cycle and getting off of that bad one.

To reiterate, the GLP-1 drugs are not what we’re talking about with the microbiome. They’re two different things. One is your body’s natural way to increase GLP-1. The other is a synthetic drug, and we are in no way suggesting that [Akkermansia] is a drug.

When you do it naturally, you’re not going to see that immediate overnight result because it’s not going to be hammering your body with high levels of GLP-1 signaling all the time. It’s going to do it the way your body naturally does it, which is that you eat a meal and then your body tells you we’re full. Over a period of time you will start to see the benefits. So, it’s not going to be an overnight change, but it will be a sustainable way.”

Probiotic Potency Explained: CFU, AFU, and TFU

When evaluating the potency of probiotics, there are three units of measurement you need to be aware of: colony forming units (CFU), active fluorescent units (AFU), and total fluorescent units (TFU).

• Colony forming units (CFU) — This is the most widely recognized and utilized metric for quantifying the number of viable bacteria or fungal cells in a probiotic product. One CFU represents a single microorganism capable of dividing and forming a colony under specific laboratory conditions. This measure is important because the activity of probiotics is associated with the number of live microorganisms that reach your gut.

Probiotic manufacturers typically list CFU counts on product labels, indicating the number of live organisms per serving. Higher CFU counts are often marketed as more potent, though the optimal CFU level can vary depending on the specific strains and the health context.

Consumers are also advised to check that the CFU amount listed on the label is specified as the CFU level at the end of shelf life (its expiration date).3 As noted by The Probiotics Institute,4 “The amount of probiotic (CFU) present on the ‘manufacturing date’ is not as important as the amount present at the ‘end of shelf life.'”

• Active fluorescent units (AFU) — This unit is a less conventional and not widely standardized measure in the context of probiotics, with the exception of Akkermansia. While CFU shows the number of bacteria that are alive, AFU refers to the total number of bacteria present, both dead and alive. It is primarily a unit used to measure enzymatic activity.

For instance, AFU could be used to evaluate the activity levels of specific enzymes produced by probiotics, which contribute to their function, such as breaking down lactose or producing vitamins. In some specialized applications, AFU is also used to assess the metabolic activity or functional potency of probiotic strains beyond mere viability.

Most companies that sell Akkermansia probiotics use AFU instead of CFU, and there’s a scientific reason for that. Akkermansia is a strict anaerobe and as such it plate-counts poorly under standard probiotic quality control conditions. Many viable-but-non-culturable (VBNC) cells aren’t captured by CFU even though they’re metabolically active.

Flow cytometry (AFU) was developed in part to address this conundrum. It labels cells with fluorescent dyes that distinguish intact membranes (live) from compromised ones, and counts each cell as it passes through a laser. In short, flow cytometry captures VBNC cells that plate counts miss.

• Total fluorescent units (TFU) — This unit measures the total bacterial mass including both live and dead cells through fluorescent labeling, and is typically used only for pasteurized products. Like AFU, TFU values are higher than CFU counts for the same sample since they include both viable and non-viable cells.

The primary difference between CFU, AFU, and TFU lies in what they measure: CFU quantifies the number of live microorganisms; AFU assesses the functional activity of those microorganisms; and TFU measures the total bacterial mass, regardless of their functional activity. While CFU is an indicator of the potential for colonization and survival of probiotics in the gut, AFU could offer additional insights into the functional capabilities of the probiotic strains.

Current Akkermansia Clinical Trials: Dosages and Applications

As research advances, numerous clinical trials are underway to evaluate the efficacy and safety of Akkermansia-based interventions.5 Published data in 2024 investigating Akkermansia have reported preliminary results,6 highlighting its potential across a range of health conditions, including infectious disease,7 immune-related disease,8 liver fibrosis,9 stress management,10 intestinal-related diseases,11 metabolic health,12 and brain function.13

These studies, which include both animal and human trials, have used therapeutic doses ranging from 100 million to 10 billion CFU per day.

In studies of obesity, Type 2 diabetes, and metabolic syndrome populations, doses around 10 billion CFU per day have been used. Researchers have examined effects on markers such as insulin sensitivity and glucose metabolism, with study sizes and durations varying.

Conversely, lower doses around 1 billion CFU per day have been examined for more gut-specific conditions and liver health,14 and even at these reduced levels, some studies report reductions in markers of intestinal inflammation.

*These findings are from research conducted in clinical settings, often in small or proof-of-concept trials. Results may not apply to all individuals.

Akkermansia Delivery and Form — What the Research Suggests

When choosing an Akkermansia probiotic, bacterial counts in the billions are typically used in published trials, though dose alone is not the whole story — the delivery method appears equally important.

For live formulations, delayed-release capsules and microencapsulation have been designed to help bacteria reach the colon intact. Without such protection, much of the live bacterial load may not survive the journey through the digestive tract.

Akkermansia is highly sensitive to oxygen, and these microbes thrive in oxygen-free environments, which makes the journey through the digestive tract challenging. Even a brief exposure to oxygen can be fatal for live cells, which is why formulations with delayed-release capsules or microencapsulation have been designed to protect the bacteria until they reach the colon.

Theoretically, a lower-dose probiotic that successfully reaches the colon may be more effective than a higher-dose product that does not, which is why the delivery method may be a far more important consideration than the labeled bacterial count.

If you are considering an Akkermansia supplement, formulations with timed-release capsules or microencapsulation have been designed to keep Akkermansia protected until it reaches the colon, typically within two to four hours.

Frequently Asked Questions About Akkermansia

Q: Does Akkermansia help with weight loss?

A: Research has examined and found associations between Akkermansia levels and metabolic markers, including body weight, appetite-related signaling, and gut health.

Q: Is Akkermansia safe?

A: Akkermansia is naturally present in a healthy microbiome. Available studies on Akkermansia supplementation, which remain limited in size and duration, have not identified serious adverse effects,15 though longer trials are needed to confirm long-term safety.

Q: Does Akkermansia cause diarrhea?

A: Akkermansia has not been linked to diarrhea in the published trial data to date. One study reported that its presence in the gut was associated with reduced occurrence of diarrhea in children.16 That said, as with any change to gut bacteria, sudden increases in any beneficial bacteria, including Akkermansia, may cause temporary digestive discomfort; gradual introduction is generally preferable.

Q: What causes low Akkermansia levels?

A: Low Akkermansia levels can be influenced by diet quality — high intake of processed foods, added sugars, and harmful fats like seed oils is associated with lower Akkermansia levels. Aging, antibiotic use, chronic stress, sedentary lifestyle,17 and metabolic conditions can also affect the composition of the gut microbiota,18 including Akkermansia levels.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified health care provider before making changes to your health regimen.

Posted in C.Diff, FMT, GLP-1, Gut, Supplements | No Comments »

Posted by: | Posted on: July 5, 2026

What Niacinamide Studies May Reveal About Cancer as a Metabolic Disease


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/06/30/niacinamide-cancer.aspx

Analysis by Dr. Joseph Mercola     June 30, 2026

niacinamide cancer

Story at-a-glance

  • Glioblastoma is considered one of the most aggressive brain cancers, with survival often limited to about a year, largely because tumors adapt by rewiring how they use nutrients and energy
  • Tumors divert vitamin B3 (niacinamide) away from normal energy production into a pathway that supports their survival, suggesting a metabolic weakness that could potentially be targeted
  • This altered pathway may drain key cellular resources, meaning cancer cells appear to burn through materials they need to grow, which may create an opportunity to disrupt their fuel supply
  • In a Science Advances study, high-dose vitamin B3 therapy was associated with improved short-term outcomes in patients, with over 80% showing no disease progression at six months in early findings, along with stronger immune activity against tumors
  • Supporting your body’s energy production and immune response through diet, lifestyle, and structured nutrient intake may help influence the same metabolic systems cancer depends on

Glioblastoma stands as one of the most aggressive brain cancers, with median survival ranging from just 12 to 15 months after diagnosis.1 This disease is characterized by persistent headaches, seizures, memory loss, confusion, and progressive neurological decline.

Once it takes hold, it disrupts normal brain function and often resists standard treatments, leaving patients with limited options and a steep decline in quality of life.

What makes this even more alarming is how little progress has occurred in extending survival, despite decades of research and treatment advances. Most patients receive a combination of surgery, chemotherapy, and radiation, along with steroids to control brain swelling.

Yet the drugs used to manage symptoms don’t act in isolation; they interact with the biology of the tumor itself in ways researchers are only beginning to map. At the same time, a growing body of research challenges the long-standing view of cancer as purely a genetic disease. Scientists now show that cancer cells rewire how they use nutrients and energy to support uncontrolled growth.

A common B vitamin sits unexpectedly at the center of this story — not because it directly treats cancer, but because of what tumors do when they encounter it, and what happens when you use that against them. Understanding how tumors hijack this nutrient pathway opens a new perspective on cancer itself, one that shifts attention away from mutations alone and toward the metabolic machinery keeping tumors alive.

Steroids and Niacinamide Expose a Metabolic Weakness in Tumors

A study published in Science Advances investigated how dexamethasone, a steroid routinely given to brain tumor patients, reshapes metabolism inside glioblastoma cells.2 Instead of focusing only on tumor size or growth, the researchers zoomed in on how cells handle niacinamide, a form of vitamin B3 that normally fuels cellular energy production.

They used advanced tools like metabolomics, which is a way to measure chemical changes inside cells, to map what happens after steroid exposure. This suggests cancer is not just about genes; it’s about how your cells process fuel.

• Tumors reroute niacinamide away from energy production — To understand why this matters, think of NAD+, the molecule your cells rely on to produce energy, as your cells’ master battery charger — present in every cell in your body and essential for hundreds of metabolic reactions. When something diverts the raw material needed to make it, cellular energy production suffers across the board.

In laboratory models (multiple glioblastoma cell lines) and human tumor samples, scientists found a dramatic shift: niacinamide stopped feeding into NAD+ and instead got converted into a different compound called N1-methylnicotinamide.*

In simple terms, the tumor diverts a key fuel source away from energy production and into a side pathway. In human patients, the study reported about a sevenfold higher buildup of this compound in tumor tissue compared to surrounding healthy brain. That suggests the tumor may be actively rewiring how it uses nutrients to survive.

• This metabolic detour becomes even more pronounced in real patients — When researchers gave labeled niacinamide to patients before surgery, they tracked exactly where it went. Inside tumor tissue, about 40% of that niacinamide ended up as N1-methylnicotinamide, while a smaller portion supported NAD+ production. That imbalance shows the tumor strongly favors this altered pathway.

This reveals a key insight: cancer cells fundamentally change how they handle nutrients you consume.

• Steroid treatment amplifies the problem inside tumors — Dexamethasone, the steroid routinely given to reduce brain swelling and keep patients comfortable, appears to accelerate the very metabolic process that helps the tumor survive. It does this by increasing the activity of an enzyme called NNMT, which acts like a switch that pushes niacinamide down the pathway the tumor has hijacked rather than toward energy production.

The study showed that steroid exposure consistently raised both the enzyme levels and the buildup of the altered metabolite in tumor cells. This effect appeared across different tumor models, showing it’s not a rare event. That means a common treatment you might assume is harmless in terms of metabolism actually reshapes how cancer cells operate at a deep level.

• Tumors accumulate far more of this compound than normal brain tissue — In studies involving animal models, levels of N1-methylnicotinamide were about 10 times higher in tumors than in healthy brain tissue. Even more striking, steroid treatment boosted this compound by 85% in tumors but not in normal brain.*

That selectivity tells you something important: the tumor environment reacts very differently to the same signal. This difference opens the door to targeting cancer without affecting healthy tissue in the same way.

Metabolic Stress Reveals a Targetable Weakness in Tumors

The researchers tested what happens when methionine, an amino acid needed for this pathway, is restricted. Under these conditions, laboratory tumor cell models showed reduced ability to maintain key chemical reactions and demonstrated slower growth.* So, when you remove part of the fuel supply that supports this altered pathway, the tumor struggles — disrupting the fuel may disrupt the system.

•  The process drains key cellular resources — Converting niacinamide into N1-methylnicotinamide consumes methyl groups; think of these as your body’s universal keys, needed to switch genes on and off, neutralize toxins, and keep cells replicating properly. When the tumor burns through them to run this pathway, it’s depleting a resource every cell in your body depends on.

The study showed a drop in a ratio that reflects the cell’s ability to carry out these reactions. When this ratio falls, the cell’s internal balance gets disrupted. This means the tumor is burning through resources in a way that weakens its own system under the right conditions.

• Scientists identified a new way to detect tumors using this pathway — Because tumors produce so much of this altered compound, researchers developed an imaging approach using labeled niacinamide to visualize tumors in real time. This gives clinicians a clearer way to see where tumors are active based on metabolism, not just structure. That shifts diagnosis from “what it looks like” to “how it behaves,” which gives a more precise picture.

• This research reframes cancer as a metabolic problem you can influence — By showing that glioblastoma cells actively divert a key nutrient away from energy production, the study highlights a core weakness in cancer metabolism. When you think about your own health, this reinforces a powerful concept: how your body processes nutrients influences disease at a cellular level.

Understanding that gives you a clearer path to take control, step by step, by focusing on the systems that drive cellular energy rather than just the symptoms you see on the surface.

• Excess niacinamide acts like a metabolic “drain” that weakens tumor fuel systems — In a related commentary, bioenergetic researcher Georgi Dinkov explains that when niacinamide levels rise, they saturate the enzyme responsible for making NAD+ and get redirected into another pathway that consumes methyl groups from methionine.3

Think of it this way: the tumor is running a metabolic process that backfires on itself. To handle all that niacinamide, it has to spend methyl groups — the same chemical currency it needs for dozens of other essential functions. Flood the system with niacinamide and you’re essentially forcing the tumor to spend faster than it can earn, draining its own reserves.

That’s the methyl sink. Framed this way, the same process observed in the study becomes a target; increasing niacinamide intake may help pressure the tumor’s fuel system by draining some of the inputs it needs to grow.

• This mechanism mimics methionine restriction, which has been associated with reduced tumor metabolism in research — Dinkov’s commentary highlights that excess niacinamide effectively forces the body into a state similar to methionine restriction, a strategy that has shown promise in slowing cancer growth in research and improving metabolic health. By consuming methionine through this pathway, tumor cells lose access to a key amino acid that acts as a metabolic regulator.

This reinforces what the study demonstrated when methionine restriction reduced tumor growth, but translates it into a practical insight: shifting how your body uses nutrients can recreate the same metabolic pressure on cancer cells without relying only on dietary restriction.

You may wonder whether this means you should also restrict methionine in your diet — a question the research raises but doesn’t fully resolve. Low-methionine diets have been studied in cancer contexts and show promise, but the more practical takeaway here is that niacinamide may create similar metabolic pressure without requiring strict dietary restriction.

High-Dose Vitamin B3 Improves Short-Term Tumor Control

If the first study provided insight on how tumors exploit niacinamide, the second asked a more direct question: could deliberately flooding the system with vitamin B3 help counteract that exploitation and influence outcomes in real patients? A study published in the Journal of Neuro-Oncology evaluated whether adding high-dose niacin, a form of vitamin B3, to standard glioblastoma treatment improves outcomes.4

Patients received niacin in controlled-release form alongside surgery, radiation, and chemotherapy. The goal was to determine whether boosting a key nutrient could shift how the disease behaves in real people, not just lab models.

Note that this study used niacin, a form of vitamin B3 that causes flushing at higher doses, rather than niacinamide, the non-flushing form discussed in the first study. Both are forms of vitamin B3 and share metabolic connections, but they act through somewhat different pathways. The clinical trial doses here were also far higher than general supplementation recommendations, and were medically supervised.

• Patients with newly diagnosed glioblastoma showed improved disease control — The study included adults between 18 and 75 years old who were newly diagnosed and eligible for standard treatment. Researchers found that adding niacin was associated with improvement in short-term outcomes.

Specifically, 82.3% of patients showed no disease progression at six months, compared to the typical rate of about 53.9% seen with standard care alone.5 That’s a 28% absolute improvement, which stands out in a disease where progress has remained stagnant for decades.

Put simply: with standard care, roughly half of patients see their tumor progress within six months. With the addition of high-dose niacin, that dropped dramatically; more than four out of five patients held stable through that same window. In a disease where every stable month matters, that’s a meaningful shift.

• Most patients maintained stability during a key early window — The six-month mark matters because glioblastoma often progresses rapidly after treatment begins. In this study, the majority of patients held stable through that window. This suggests niacin may have helped delay tumor progression during one of the most vulnerable phases of the disease. This translates into more time with controlled disease and fewer immediate setbacks.

Patients in this study received niacin at the start of standard therapy rather than later in disease progression. That timing aligns with the observed improvements in early disease control. It suggests that influencing metabolism and immune activity upfront may create a stronger impact than waiting until the tumor advances further.

• Higher doses reached a defined threshold for safety and effectiveness — Researchers gradually increased niacin doses from 500 milligrams (mg) up to 3,000 mg per day to identify the optimal range. They determined that 2,000 mg daily provided the best balance between effectiveness and tolerability. Side effects were mostly mild, with flushing being the most common.

• Niacin restored immune cell function that tumors suppress — The study reported that niacin improved the activity of immune cells responsible for attacking cancer. Glioblastoma weakens these cells, reducing their ability to respond. Niacin appeared to reverse that suppression, allowing immune cells to recognize and target tumor cells more effectively.

Study author Wee Yong, Ph.D., explained, “Niacin treatment rejuvenates immune cells so they can do what they are supposed to do: attack and kill the cancer cells.”6 The tumor had shut down the immune response, and niacin helped switch it back on.

• The findings highlight a combined metabolic and immune strategy — By improving both disease control and immune activity, the study points to a dual-action effect. Instead of targeting the tumor from a single angle, niacin supports internal systems that influence how the tumor grows and how your body responds. This reinforces a key takeaway: changing how your body processes nutrients and supports immune function may influence the trajectory of the disease.

Target the Metabolic and Immune Drivers Behind Tumor Growth

Everything described above points to the same conclusion: glioblastoma isn’t just a tumor problem, it’s a systems problem. The tumor wins because two things break down simultaneously — your cells’ ability to produce energy efficiently, and your immune system’s ability to recognize and fight back. The steps below address both of those foundations.

They are not a substitute for medical treatment, but they work on the same metabolic terrain the research describes. Research suggests that addressing both systems may influence how the disease behaves. Strengthening energy pathways while supporting immune activity may help alter the internal environment that tumors depend on. Here are the steps that address that foundation directly:

1. Restore steady cellular energy with adequate carbohydrates — Cells rely on consistent fuel to maintain efficient energy production. Daily carbohydrate intake of about 250 grams supports mitochondrial function and may help reduce exposure to stress-driven pathways.

If digestion feels compromised, starting with whole fruit and white rice helps ease the transition before adding more complex carbohydrates. This step supports general mitochondrial health rather than directly targeting the niacinamide pathway, but stable cellular energy production is the foundation everything else builds on.

2. Strengthen immune response with nutrient-dense vitamin B3 sources — The study showed that niacin improved immune cell function that tumors had suppressed. Regular intake of whole-food sources of vitamin B3 such as grass fed beef supports both energy production and immune readiness.

Consistency matters because immune cells require steady nutrient availability to stay active and responsive. Grass fed beef liver is particularly worth including; it contains dramatically more niacin per serving than muscle meat and also provides other B vitamins that support the same energy pathways discussed in the research.

3. Eliminate seed oils to reduce metabolic and immune disruption — Excess linoleic acid (LA) from vegetable oils like soybean, corn, sunflower, and canola interferes with mitochondrial function and increases inflammatory stress. Removing these oils and replacing them with stable fats such as grass fed butter, ghee, or tallow reduces one of the major drivers of cellular dysfunction. This change supports both energy production and immune signaling.

4. Optimize protein intake to support repair and immune resilience — Protein intake around 0.8 grams per pound (or 1.76 grams per kilogram) of lean body mass supports tissue repair, enzyme production, and immune cell function. Including roughly one-third from collagen-rich sources like slow-cooked meats or bone broth helps maintain structural and metabolic balance without overwhelming the system.

5. Use structured niacinamide intake to reinforce energy metabolism — Small, evenly spaced doses support steady NAD+ production instead of overwhelming your system at once. A practical approach involves about 50 mg of niacinamide taken three times per day, spaced evenly — upon waking, midday, and before bed.

This is niacinamide, the non-flushing form of vitamin B3, used here to support NAD+ production and mitochondrial energy metabolism as a general health practice. This is distinct from the high-dose niacin used in the clinical trial, which was medically supervised and targeted immune activation at doses up to 2,000 mg daily. Do not attempt to replicate the clinical protocol without physician oversight.

*These findings are based on laboratory and animal research. Results from these models may not directly apply to human health outcomes.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your health regimen.

FAQs About Niacinamide and Cancer

Q: What makes glioblastoma so difficult to treat?

A: Glioblastoma is an aggressive brain cancer that grows rapidly and disrupts normal brain function, leading to symptoms like seizures, memory loss, and confusion. Standard treatments have remained largely unchanged for decades, with average survival still around 12 to 15 months. The tumor also resists therapy by changing how it uses nutrients and suppressing the immune system.

Q: How does niacinamide affect cancer metabolism?

A: Research suggests tumors may divert niacinamide away from energy production and into a pathway that drains key cellular resources while supporting the tumor’s survival. Paradoxically, this may create a vulnerability — the same pathway that helps the tumor also depletes materials it depends on, which is why researchers see it as a potential target.

Q: Why is cancer now being viewed as a metabolic disease?

A: New findings suggest cancer may not be driven only by genetic mutations. Tumors actively rewire how they use nutrients and produce energy. This could mean that the internal environment of your cells, including how nutrients like vitamin B3 are processed, could directly influence whether cancer grows or struggles.

Q: Can vitamin B3 improve outcomes in glioblastoma?

A: Clinical research found that adding high-dose niacin to standard treatment improved short-term disease control. About 82.3% of patients had no tumor progression at six months, compared to roughly 53.9% with standard care alone. The study also suggested niacin may have helped restore immune cell activity and support the body’s ability to attack the tumor.

Q: What practical steps support healthier cellular energy and immune function?

A: The most effective approach focuses on restoring how your cells produce energy and how your immune system responds. This includes maintaining steady carbohydrate intake, avoiding vegetable oils that disrupt mitochondrial function, eating nutrient-dense foods rich in vitamin B3, optimizing protein intake, and using structured niacinamide intake to support NAD+ production. These steps may support the same metabolic pathways highlighted in the research.

Posted in Cancer, Supplements | No Comments »

Posted by: | Posted on: June 19, 2026

Ancient herb shown to dramatically reduce one of cancer’s most debilitating side effects

Reproduced from original article:
https://www.naturalhealth365.com/ancient-herb-shown-to-dramatically-reduce-one-of-cancers-most-debilitating-side-effects.html

by:  | April 17, 2026

ancient-herb(NaturalHealth365)  For thousands of years, healers across Asia relied on a single root to restore energy, strengthen the body’s defenses, and help the sick recover their vitality.  Western medicine largely dismissed this tradition as folklore.  Now, a 2025 peer-reviewed analysis is forcing a second look — and the numbers are hard to ignore.

Researchers publishing in Integrative Cancer Therapies reviewed eight randomized controlled trials examining astragalus membranaceus — known in traditional Chinese medicine as Huang Qi — in cancer patients suffering from one of the most common and least-addressed problems in natural health: debilitating, persistent fatigue.  Across 804 patients, the results showed that this ancient herb delivered measurable, statistically significant relief where so many other approaches have fallen short.

The fatigue nobody talks about — and what finally helps

Most people focus on the diagnosis itself and forget that what follows often strips people of their quality of life just as completely.  Cancer-related fatigue affects somewhere between 70% and 92% of people with cancer, and unlike ordinary tiredness, no amount of rest resolves it.  The body simply cannot restore what is being lost.  Western medicine has no approved pharmaceutical treatment for this condition; patients are often simply told to push through.

The 2025 meta-analysis found something very different when astragalus was added to care.  Patients receiving astragalus were 55% more likely to experience meaningful improvement in fatigue than those who did not.  Quality-of-life scores told the same story — astragalus-treated patients were 57% more likely to show measurable improvement there, too.  Adverse effects across all included studies were rare and mild, resolving on their own without intervention.

What makes this root so powerful

Astragalus membranaceus is not a simple supplement.  The root contains several classes of active compounds – polysaccharides, saponins, flavonoids, and a compound called astragaloside IV – each working through distinct pathways inside the body.  Together, they address several of the underlying reasons why cancer and chronic illness drain energy so completely.

Research published in the Journal of Ethnopharmacology found that astragalus polysaccharides help restore the bone marrow’s ability to produce healthy blood cells, one of the key reasons people with serious illness feel so profoundly depleted.  Other studies found that astragalus raises critical immune cell populations while simultaneously reducing inflammatory signals – including TNF-α and IL-1β – that silently exhaust the body’s reserves day after day.

Research published in Medical Oncology found that adding astragalus to care in patients with advanced lung cancer improved both quality of life and survival outcomes compared to care without it.

Perhaps most telling of all: Taiwan’s health authorities have officially approved an astragalus polysaccharide preparation called PG2 as a treatment for cancer-related fatigue in patients with advanced cancer, making Taiwan the only country in the world to do so, based on clinical trial evidence.

This herb has been doing this for 2,000 years — science just caught up

Astragalus has been a cornerstone of traditional Chinese medicine for over two millennia.  Used specifically to tonify qi – the body’s vital energy – and build resistance to disease, large analyses of Chinese herbal medicine prescribing patterns found astragalus was the single most frequently used herb in cancer care over a 20-year span.

Practitioners across generations have observed what researchers are only now quantifying: that this root helps the body maintain its strength and defenses under conditions that would otherwise exhaust them.

The immune benefits extend well beyond fatigue.  Astragalus stimulates natural killer cell activity, enhances macrophage function, and regulates the inflammatory cascade – all critical to maintaining a body environment that resists disease rather than accommodates it.

Natural solutions to rebuild your immune strength

Start with astragalus as a daily foundation, not a crisis response.  The research consistently shows that astragalus works best as an adaptogen – something that builds strength over time rather than producing an overnight result.  Traditional preparation involves simmering dried astragalus root in soups and broths to extract the water-soluble polysaccharides most studied for their benefits.  Standardized extracts, tinctures, and capsules are also widely available; look for products that specify astragalus membranaceus and have documented polysaccharide content.  Consistent daily use over weeks and months is what the evidence supports.

Layer in other well-studied immune-supporting botanicals.  Medicinal mushrooms – reishi, turkey tail, and shiitake – contain beta-glucans that work alongside astragalus polysaccharides through complementary pathways.  Elderberry, andrographis, and cat’s claw each bring distinct mechanisms.  Building a layered approach provides more resilient immune support than relying on any single herb.

Feed your immune system through anti-inflammatory nutrition.  No supplement can outwork a diet that constantly fans the flames of inflammation.  Wild-caught fatty fish, organic dark leafy greens, turmeric, ginger, and extra virgin olive oil all actively support the immune environment.  Removing refined seed oils, added sugars, and ultra-processed foods – which fuel the same inflammatory signaling astragalus works to calm – matters just as much as what you add.

What your immune system is really capable of

The story of astragalus is ultimately a story about what the body can do when properly supported.  Across 804 cancer patients in randomized trials, a root used safely for thousands of years delivered real, measurable results for people who were told nothing could be done about their exhaustion.

Sources for this article include:

NIH.gov
NIH.gov
NIH.gov

Posted in Cancer, Food, Supplements | No Comments »

Posted by: | Posted on: June 10, 2026

The forgotten organ that can predict your risk of infections and premature death by up to 50%

Reproduced from original article:
https://www.naturalhealth365.com/the-forgotten-organ-that-could-predict-how-long-you-live-researchers-now-confirm.html

by:  | June 6, 2026

thymus-health(NaturalHealth365)  Most adults have never given a thought to their thymus.  Unfortunately, Western medicine rarely mentions this organ after childhood.  On top of that, the conventional scientific community falsely believes that the thymus becomes largely irrelevant once the body matures.  Now two landmark studies published in Nature are overturning that assumption entirely, and the numbers are impossible to dismiss.

Researchers at Mass General Brigham used artificial intelligence to analyze CT scans from more than 25,000 adults.  The AI assessed each participant’s thymus and generated a thymic health score.  People with the highest scores had a 50% lower risk of death from any cause and a 63% lower risk of dying from cardiovascular disease.

Remarkably, those adults also showed a 36% lower risk of developing lung cancer.  A second study analyzed outcomes in 3,476 cancer patients receiving immunotherapy.  Stronger thymic health was associated with a 37% lower risk of cancer progression and a 44% lower risk of death.

Your protection against infections and disease

The thymus sits in the chest, just behind the breastbone.  During childhood, the organ trains T cells, the specialized immune defenders that protect the body from infection and disease.

Cancer defense and cellular repair both depend on these cells.  After puberty, the thymus begins to shrink and produces fewer new T cells.  Consequently, most physicians stopped paying attention to the thymus, assuming the work was finished.

However, research from Mass General Brigham reveals that the thymus continues to produce T cells throughout adulthood.  The quality of that ongoing production matters enormously.

Moreover, adults with healthier thymuses maintain greater immune cell diversity.  That diversity, the research shows, translates directly into lower rates of chronic disease and longer survival.  “The thymus has been overlooked for decades and may be a missing piece in explaining why people age differently,” said lead researcher Hugo Aerts, PhD.

Why thymic decline happens faster in some people than others

The research did not simply confirm that thymic health predicts longevity.  Importantly, the team identified specific factors associated with accelerated decline.  Chronic inflammation, smoking, and high body weight each correlated with significantly poorer thymic health scores.

That finding matters because the research places a meaningful degree of control over immune aging in each individual’s hands.  Rather than leaving the outcome entirely to genetics or time, lifestyle choices now emerge as direct determinants of thymic health.

A person managing chronic inflammation, reducing body weight, and avoiding tobacco is also protecting the immune system, which is responsible for long-term disease resistance.  The research makes that connection direct and specific.

What the immunotherapy finding reveals about immune capacity

The second study’s finding deserves separate consideration.  Researchers analyzed cancer patients receiving immune checkpoint inhibitors.  These treatments work by removing molecular brakes that cancer cells place on T cells, allowing those immune cells to resume attacking tumors.

Patients with the strongest thymic health showed a 37% lower risk of cancer progression and a 44% lower risk of death.  In fact, those results held even after accounting for tumor type, treatment protocol, and other patient variables.

These finding suggests the thymus functions as a reservoir of immune capacity.  When that reservoir is depleted over decades of inflammation and poor metabolic health, the T cells available to respond to treatment become fewer and less diverse.  As a result, the immune system’s ability to fight cancer may be substantially shaped years before a diagnosis is ever made.

Steps that protect thymic function starting now

Address chronic inflammation.  The research confirms that systemic inflammation accelerates thymic decline.  A diet rich in organic dark leafy greens, organic berries, and extra-virgin olive oil provides anti-inflammatory polyphenols, and antioxidants.  Together, those compounds directly reduce the inflammatory burden on immune tissue.

Curcumin from turmeric has strong research support for reducing systemic inflammatory markers.  In addition, high-quality omega-3 foods or supplementation can help to reduce the risk of inflammation at the cellular level.

Support metabolic health as inseparable from immune resilience.  High body weight was directly linked to poorer thymic health in the research.  Reducing visceral fat through consistent daily movement and a diet low in refined carbohydrates creates a metabolic environment that supports rather than burdens the immune system.

Targeted supplementation with berberine further improves insulin sensitivity through pathways that reduce systemic inflammation.  And, finally, magnesium can help you with both blood sugar regulation and the stress response, reducing one of the least-recognized contributors to chronic inflammation.

Prioritize nutrients that support T cell development and immune diversity.  Zinc plays an essential and largely underappreciated role in thymus function and T cell maturation.

Research consistently links zinc deficiency to accelerated thymic atrophy and reduced immune cell diversity.  Plus, selenium supports the antioxidant defenses that protect thymic tissue from oxidative damage.

Vitamin D, maintained at functional blood levels between 50 and 70 ng/mL, supports immune genes critical for T cell activation.  But, keep in mind, most people on standard supplement amounts will not reach that target without testing and adjustments, as needed.

Together, these targeted nutrients supply the biological inputs the thymus depends on to remain functional across the lifespan.

The immune system builds future resilience long before disease arrives

Overall, a 50% reduction in all-cause mortality linked to a single organ’s health status is a finding that should reshape how adults think about immune function.  Most people manage symptoms as they appear.  Very few consider the underlying immune infrastructure that determines whether those symptoms ever develop.

Sources for this article include:

Massgeneralbrigham.org
Sciencedaily.com

Posted in Immunity, Inflammation, Minerals, Nutrition, Obesity, Supplements, Thymus | No Comments »

Posted by: | Posted on: April 17, 2026

Aspirin May Fight Cancer — But Not for the Reason You Think


Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/04/13/aspirin-salicylate-cancer.aspx

Analysis by Dr. Joseph Mercola     April 13, 2026

aspirin salicylate cancer

Story at-a-glance

  • Scientists built the biggest drug-testing dataset in history — 100 million cell measurements — and asked a question nobody had asked before: “Does this drug push cancer cells back toward being normal, healthy cells?”
  • When they tested this new approach on colon cancer, the drugs already known to work best in patients rose straight to the top — proving the method works
  • The biggest surprise was that plain salicylate — which is aspirin with its signature ingredient removed — was better at pushing colon cancer cells back toward normal than aspirin itself
  • This is a huge clue. The part that was removed is the exact part that gives aspirin its famous anti-inflammatory power. So, aspirin’s cancer-fighting ability is coming from somewhere else entirely
  • Lab studies have now figured out where: salicylate switches on your cells’ built-in energy sensor, which shuts down a key cancer-driving gene and activates your body’s own natural tumor defense system — none of which has anything to do with inflammation

I’ve written before about the many health benefits of aspirin that many people don’t hear about — from protecting your heart and preventing cancer to boosting your metabolism and balancing your hormones.

But new research is revealing something about aspirin and cancer that changes the story in ways nobody expected. It starts with a completely different way of looking at what drugs actually do to cancer cells. And it ends with a finding that turns decades of assumptions upside down.

How Cancer Drugs Have Always Been Tested — and Why It Misses So Much

For as long as modern cancer research has existed, scientists have tested drugs the same basic way. They put cancer cells in a dish, add the drug, and wait to see if the cells die. If most of them die, the drug is a winner. If they survive, the drug gets tossed.

This sounds perfectly reasonable. But stop and think about what it actually measures. It measures one thing and one thing only: death. Here’s the problem with that.

• Cancer isn’t just one thing going wrong — A cancer cell is a normal cell that has gone haywire in many ways at the same time. Think of it like a car where the engine is racing, the brakes are cut, and the steering is locked — all at once. Killing the car — running it into a wall — is one way to stop the problem. But what if you could just fix the engine, unlock the steering, reconnect the brakes, and turn the headlights back on? You would have a working car again.

• Cancer cells aren’t alien invaders — They’re your own cells running the wrong program. And a drug that could fix part of that program — slow the engine down, reconnect some of the brakes — would be completely invisible in the standard drug test, because the cells didn’t die. How many valuable drugs have been thrown in the trash because we were only looking at one thing?

Every Cell Runs a Program — Cancer Cells Are Running the Wrong One

To understand the new approach, you first need to understand one simple idea about how your cells work.

• Every cell in your body contains the same DNA, the same complete set of instructions — What makes a colon cell different from a brain cell or a skin cell is not which instructions they have, but which instructions they’re actually using. Out of roughly 20,000 genes, each cell type switches on a specific set and keeps the rest turned off. This pattern — which genes are on and which are off — is the cell’s program. It is what gives the cell its identity.

• Think of it like a massive mixing board in a recording studio — There are 20,000 sliders. A healthy colon cell has each slider set to a very specific position. The overall setting produces “healthy colon cell.” When a cell becomes cancerous, the sliders get moved. Some that should be turned down get cranked up. Others that should be up get pushed to zero.

The mixing board is still there, the sliders still work, but the overall setting now produces “cancer cell” instead of “healthy colon cell.” This is a crucial point. The cancer cell hasn’t been destroyed or replaced. It’s your cell, running the wrong settings.

A 100-Million-Cell Dataset Made a New Question Possible

Researchers at a company called Tahoe Therapeutics have built something that has never existed before.1 They measured how 1,100 different drugs changed the genetic settings in cancer cells — one cell at a time — across 50 different cancer cell lines. The result is a dataset containing 100 million individual cell measurements from 60,000 separate drug experiments. That’s 50 times more data than everything publicly available before it — combined.

• With this enormous dataset, they could finally ask the question that nobody had enough data to answer before — For every drug, does it push the cancer cell’s gene settings back toward the healthy pattern? Here’s how they did it. First, they used data from real colon cancer patients to map out exactly how the gene settings differ between healthy colon tissue and cancerous colon tissue. That gave them the “disease signature” — a precise measurement of what went wrong.

• Then, for each drug in their collection, they measured what it did to the mixing board — Did it move the sliders back toward the healthy positions? Or did it push them even further in the wrong direction? Or did it just move them to some random new pattern?

• They scored every drug with a simple number — A strong negative score meant the drug was reversing the cancer pattern — pushing the cell back toward normal. They call this “cell-state reversal.”2

The First Test: Does It Match What Doctors Already Know?

Before you trust a new method, you need to check it against reality. If drugs that are already proven to work in colon cancer patients don’t score well on this test, the whole approach is worthless. So, the researchers checked. And the results were clear.

• Top-scoring drugs matched the exact mutations driving colon cancer growth — The drugs that scored highest for pushing colon cancer cells back toward normal were exactly the ones that target the specific genetic mutations most commonly found in colon cancer — MEK inhibitors, BRAF inhibitors, KRAS inhibitors, and PI3K pathway inhibitors.

These are the drugs oncologists already use because clinical experience has shown they work. The framework figured this out on its own, from the data alone, without being told which drugs are effective in patients.

• It even caught subtleties that match real clinical practice — Among chemotherapy drugs, the ones that target DNA — like 5-fluorouracil and oxaliplatin, which are the backbone of standard colon cancer treatment — scored higher than the ones that target the cell’s internal scaffolding, called microtubule inhibitors. Microtubule inhibitors aren’t part of the standard treatment for colon cancer, and the data reflected that perfectly.

Now Here’s Where It Gets Really Interesting: The Aspirin Surprise

Among all the drugs tested, one result stood out as genuinely unexpected. It involved one of the cheapest, oldest, and most widely available medicines on Earth.

When the researchers looked at aspirin and its close chemical relatives in the dataset, they found that sodium salicylate — which is aspirin with one specific piece removed — produced stronger cancer-state reversal than aspirin itself. To understand why this is such a big deal, you need to know one thing about aspirin’s chemistry. Don’t worry — it is simpler than it sounds.

• Aspirin’s chemical name is acetylsalicylic acid — It’s made of two parts: salicylic acid, which comes from willow bark and has been used as medicine for thousands of years, and an acetyl group, which was attached to the salicylic acid by chemists at Bayer in 1897 to make it easier on the stomach.

• That acetyl group isn’t just a packaging improvement — It’s the part that gives aspirin its most famous ability — the power to shut down an enzyme called cyclooxygenase, or COX for short. COX produces inflammatory chemicals called prostaglandins. When aspirin blocks COX, inflammation goes down.

That’s how aspirin reduces pain, reduces fever, thins your blood, and — most researchers assumed — fights cancer. Here’s the catch. If aspirin’s anticancer power comes from blocking COX, then removing the acetyl group — the part that does the COX blocking — should make it worse at fighting cancer, not better.

• But the Tahoe data showed the exact opposite — Salicylate, without the acetyl group, was better at reversing the cancer cell’s genetic program than aspirin with it. That means the cancer-fighting effect isn’t coming from COX inhibition. It’s coming from the salicylate itself — through a completely different mechanism that nobody was paying attention to.

So, What Is Salicylate Actually Doing? The Answer Is Elegant

The Tahoe data showed what salicylate does to cancer gene patterns. But other research teams have been uncovering how it does it, and the picture is remarkably coherent. Your cells have an energy sensor — think of it as a fuel gauge.

It’s a protein called AMPK, which stands for AMP-activated protein kinase, but all you need to know is that AMPK is the alarm system that goes off when your cell’s energy balance changes.3 It’s one of the most powerful metabolic switches in your body. Salicylate switches AMPK on.4 When AMPK activates, it triggers a chain of events that’s devastating to cancer cells. Here’s the chain, step by step:

• Step 1: AMPK shuts down c-MYC — One of the most important genes in cancer is called c-MYC. Think of c-MYC as the gas pedal for cell growth. In a healthy cell, it’s carefully controlled. In many cancers — especially colon cancer — c-MYC is jammed to the floor, driving the cell to grow and divide nonstop. Salicylate-activated AMPK grabs c-MYC and tags it for destruction. The gas pedal gets released.

A 2025 study using a mouse model of colon cancer confirmed this. Mice given salicylate had dramatically lower c-MYC levels in their colon cells, and they developed fewer tumors.5

• Step 2: With c-MYC gone, a protective system switches on — Here’s something beautiful about your biology. You already have a built-in tumor defense system — a set of genes that suppress cancer. One of the most important is a group of tiny molecules called miR-34a and miR-34b/c.6 These are microRNAs — small pieces of genetic material that act like off-switches for cancer-promoting genes. They work by silencing specific genes that cancer cells depend on to grow and spread.

Normally, a protein called NRF2 — think of it as your cell’s fire alarm system — is supposed to activate these cancer-fighting microRNAs. But c-MYC sits on top of NRF2 and keeps it silenced. It’s like a bully sitting on the fire alarm so nobody can pull it. When salicylate removes c-MYC, NRF2 is free. It activates miR-34a and miR-34b/c. Your body’s own tumor suppression system comes back online.

• Step 3: The cancer cells lose their ability to spread — When researchers blocked miR-34a and miR-34b/c in the lab, salicylate’s ability to stop cancer cell migration and invasion largely disappeared. That tells you these microRNAs are the key weapons. Salicylate isn’t directly attacking the cancer — it’s rearming your body’s own defense system.

• And here’s the most important part — Normally, miR-34 depends on a tumor suppressor gene called p53 — often called the “guardian of the genome.” But p53 is the single most commonly broken gene in human cancer. In more than half of all cancers, p53 doesn’t work. Salicylate’s pathway bypasses p53 entirely. It activates miR-34 through NRF2 instead.

This means it could theoretically work in the very cancers that have already lost their most important natural defense, which is exactly the cancers that need help the most. None of this involves COX inhibition. None of it requires the acetyl group. This is the ancient willow bark compound doing something we are only now beginning to understand.

The Clinical Trial That Changed the Guidelines

While these laboratory discoveries were piling up, a major clinical trial was delivering results that would change how oncologists treat colon cancer. The trial used aspirin, not salicylate — but remember, your body rapidly strips the acetyl group off aspirin and converts it into salicylic acid. So, every aspirin patient in this trial was effectively being dosed with salicylate.

The ALASCCA trial, published in the New England Journal of Medicine in September 2025, was the gold standard of medical research — a double-blind, randomized, placebo-controlled trial, meaning neither the patients nor the doctors knew who was getting aspirin and who was getting a sugar pill.7

It was conducted across 33 hospitals in four countries: Sweden, Denmark, Finland, and Norway. The trial focused on patients with stage I through III colon and rectal cancer whose tumors carried mutations in something called the PI3K pathway — a growth-signaling system that, when broken, helps cancer cells multiply unchecked. You don’t need to remember that name.

What matters is that these mutations are found in more than one-third of all colorectal cancers — so this isn’t a rare subtype. It is a big chunk of patients. After surgery, patients were randomly assigned to take either 160 milligrams (mg) of aspirin or a placebo every day for three years.

• The results were remarkable — Among patients with the most common type of PI3K mutation, aspirin cut the three-year recurrence rate roughly in half — from 14.1% with placebo down to 7.7% with aspirin.

The benefit held up across every subgroup the researchers checked: men and women, all disease stages, colon and rectal cancer, and regardless of whether patients also received chemotherapy. Lead researcher Anna Martling of the Karolinska Institutet in Stockholm called it “a clear example of how we can use genetic information to personalize treatment and at the same time save both resources and suffering.”8

• The National Comprehensive Cancer Network has since updated its recommendations — This organization, which writes the treatment guidelines oncologists follow, now formally recommend genetic testing for PIK3CA mutations in stage II-III colon cancer, and for patients who carry the mutation, three years of low-dose aspirin after surgery.9 This makes aspirin one of the first dirt-cheap, widely available drugs to be officially integrated into precision cancer treatment guidelines.

Aspirin Also Helps Your Immune System See the Cancer

The ALASCCA trial proved aspirin works in patients. But there’s another dimension to the story — aspirin may also be helping your immune system do its own cancer-fighting job. A 2024 study published in the journal Cancer found that regular aspirin use was linked to activation of immune surveillance in colorectal cancer patients.10 Here’s what that means in plain English.

• Your immune system is supposed to recognize and destroy cancer cells — That’s one of its main jobs. But cancer cells are sneaky — they learn to hide from your immune system by covering up the markers that would identify them as abnormal.

• Regular aspirin use linked to less spread and stronger immune attack — The researchers found that colon cancer patients who regularly used aspirin had two things going for them. First, they had fewer cancer cells that had spread to their lymph nodes. Second, they had more immune cells infiltrating their tumors — meaning the immune system was actually showing up to fight.

• Aspirin helps cancer cells reveal themselves to immune system defenses — When they treated colon cancer cells with aspirin in the lab, they found aspirin increased the expression of a protein called CD80 on the surface of the cancer cells. CD80 is like a flag that says “I am abnormal — come get me.”

It helps cancer cells present themselves to your T cells — the soldiers of your immune system — so they can be recognized and destroyed. In simple terms, aspirin was pulling the camouflage off the cancer cells so the immune system could see them.

Aspirin’s Benefits Go Far Beyond Cancer

As I’ve detailed in previous articles, aspirin’s health benefits reach into nearly every major organ system. Here’s an updated picture based on the latest research.

• Your liver — A clinical trial found that 81 mg of aspirin daily led to a 17.3% decrease in the amount of fat stored inside liver cells over six months, while patients taking a placebo saw their liver fat increase by 30.3%.11 Aspirin also improved markers of inflammation and scarring in the liver — two key factors in the progression of fatty liver disease.

• Your blood sugar — An analysis of 16,209 adults aged 65 and older found that low-dose aspirin was associated with a 15% lower risk of developing Type 2 diabetes and a slower rise in fasting blood sugar levels over time.12

• Your survival in critical care — A large study of 146,191 intensive care unit (ICU) patients found that aspirin use during ICU stays was linked to significantly lower death rates within 28 days, particularly in patients with widespread inflammation.13

• Your brain — Research found that low-dose aspirin use for more than 10 years was associated with a 31% reduced risk of Alzheimer’s disease, a 69% reduced risk of vascular dementia, and a 54% reduced risk of dementia from any cause — particularly in patients who already had heart disease.14

• Your lungs — Aspirin has been shown to reduce the scarring process in lung tissue by switching on a cellular recycling system called autophagy — your cells’ built-in method of cleaning out damaged proteins and preventing scar tissue from building up. When researchers blocked autophagy, aspirin’s anti-scarring effects disappeared, confirming that this recycling process is how aspirin protects the lungs.15

• Your metabolism — Aspirin helps your cells burn glucose for energy, reduces the release of linoleic acid (LA) — a harmful omega-6 fat — from your fat stores, lowers your cortisol levels, and increases your metabolic rate by partially uncoupling your mitochondria.16 Think of uncoupling as your cellular engines running a bit hotter and burning more fuel, which is why aspirin may help with weight management.

What About Salicylate and Willow Bark?

The Tahoe finding — that salicylate reversed the colon cancer gene signature more strongly than aspirin — has a practical implication that’s easy to overlook. When you take aspirin, your body quickly strips off the acetyl group and converts it into salicylic acid. That is what circulates in your bloodstream. That is what your cells actually see.

• Aspirin’s lasting anticancer effects stem from its salicylate metabolite — The acetyl group does its COX-blocking work during the brief window before it gets removed, but the salicylate metabolite is what sticks around and does the long-term work.

This means the anticancer effects are most likely coming from the part of aspirin that’s identical to what you would get from willow bark — the plant medicine that humans have used for thousands of years, long before Bayer attached an acetyl group to it in 1897.

• Willow bark provides the same active compound linked to anticancer benefits — If you’re sensitive to aspirin — if it bothers your stomach or you can’t take it for other reasons — this is important news. A salicylic acid supplement or willow bark extract delivers the very compound that the largest drug-response dataset in history identified as more effective than aspirin at pushing cancer cells back toward normal.

• Standardized willow bark dosing approximates common low-dose aspirin effects — For dosage, to approximate the effects of 81 mg of aspirin, you would need 400 mg to 800 mg of willow bark extract standardized to 15% salicin. To match the effects of a full 325 mg aspirin, you would need roughly 1 to 2 grams of standardized extract.

• Immediate-release aspirin with minimal additives aligns best with research dosing — If you prefer aspirin, opt for immediate-release, uncoated versions. Avoid coated extended-release formulations because of their additives. Check the inactive ingredients list — corn starch should be the only one listed. A dosage of 81 mg to 325 mg daily, taken with your largest meal, is the range supported by the current research.

Why This Changes How We Think About Medicine

Step back for a moment and consider what’s happened here. For decades, the entire cancer drug discovery pipeline has been built around one question: does this drug kill cancer cells? Billions of dollars, thousands of clinical trials, an entire industry — all oriented around cell death as the primary measure of success.

Now, using the largest dataset of its kind ever assembled, researchers have shown that you can score drugs by a completely different measure — how well they push diseased cells back toward being healthy cells. And when they did this, the results matched known clinical reality with remarkable precision.

• More importantly, this approach revealed something that the old method couldn’t see — A simple, ancient, inexpensive compound — salicylate, the active heart of willow bark — is doing something to colon cancer cells that ranks alongside purpose-built targeted cancer drugs. Not by killing the cells. By fixing them.

• This framework applies anywhere a disease is fundamentally a cell running the wrong program — Autoimmune conditions where immune cells attack your own body. Brain diseases where neurons lose their specialized function. Scarring diseases where cells produce too much fibrous tissue.

In all of these cases, the right question is not “can we kill the cell” but “can we push the cell back toward normal.” How many other cheap, safe, widely available compounds have cancer-fighting properties that we have completely missed because we were only measuring the wrong thing? We may be about to find out.

The Bottom Line

We’ve spent decades arguing about aspirin and cancer while asking the wrong questions. We asked whether aspirin kills cancer cells. The answer was not very impressive. We asked whether aspirin’s anti-inflammatory COX inhibition reduces tumor-promoting inflammation. The evidence was mixed.

But now, using 100 million cell measurements and a fundamentally different scoring method, we can see that salicylate — the ancient compound at the heart of aspirin, the same molecule found in willow bark — is doing something far more sophisticated than anyone imagined.

It’s not just killing cancer cells or reducing inflammation. It switches on your cells’ energy sensor, shuts down a major cancer-driving gene, reactivates your body’s built-in tumor defense, and pushes cancer cells back toward normal.

And it does all of this through a pathway that has nothing to do with COX inhibition — the mechanism many people assumed was responsible. This is a common, safe, inexpensive medicine whose full power we are only now beginning to understand — and it deserves far more attention than it’s getting.

FAQs About Aspirin and Cancer

Q: Why are researchers rethinking how aspirin affects cancer?

A: A drug-testing framework analyzed about 100 million individual cell measurements to see whether drugs push cancer cells back toward a healthy state rather than simply killing them. Using this method, salicylate — aspirin without its acetyl component — ranked higher than aspirin at reversing the gene patterns associated with colon cancer, suggesting the anticancer effect works through a different mechanism than previously assumed.

Q: What part of aspirin appears responsible for the cancer-related effects?

A: Evidence indicates the salicylate portion — the same compound derived from willow bark — drives the key biological changes. After ingestion, aspirin is rapidly converted into salicylic acid in your body, which persists longer in circulation and is likely responsible for many downstream cellular effects linked to tumor suppression.

Q: How does salicylate influence cancer biology at the cellular level?

A: Research shows salicylate activates AMPK, a cellular energy sensor that suppresses the cancer-promoting gene c-MYC and enables activation of tumor-suppressive microRNAs such as miR-34. This pathway operates even when p53 — commonly impaired in cancer — is dysfunctional, which helps explain broad relevance across tumor types.

Q: What clinical evidence supports aspirin use in colorectal cancer?

A: A randomized clinical trial published in The New England Journal of Medicine found daily aspirin after surgery reduced three-year recurrence from 14.1% to 7.7% among patients with PI3K-pathway mutations.17 These findings contributed to updated guidance recommending genetic testing for PIK3CA mutations and consideration of post-surgical low-dose aspirin in eligible patients.

Q: How do aspirin and willow bark compare in practical terms?

A: Because aspirin is converted into salicylate, both aspirin and standardized willow bark extracts deliver related active compounds. Approximate equivalence described in research discussions suggests 400 to 800 mg of willow bark extract standardized to 15% salicin corresponds to typical low-dose aspirin exposure, while higher extract amounts may approximate full-strength aspirin ranges. Clinical dosing equivalence remains an area of ongoing research.

Posted in Cancer, Immunity, Supplements | No Comments »

Next Entries »